nih-gov/www.ncbi.nlm.nih.gov/omim/609310

3040 lines
228 KiB
Text

<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en-us" xml:lang="en-us" >
<head>
<!--
################################# CRAWLER WARNING #################################
- The terms of service and the robots.txt file disallows crawling of this site,
please see https://omim.org/help/agreement for more information.
- A number of data files are available for download at https://omim.org/downloads.
- We have an API which you can learn about at https://omim.org/help/api and register
for at https://omim.org/api, this provides access to the data in JSON & XML formats.
- You should feel free to contact us at https://omim.org/contact to figure out the best
approach to getting the data you need for your work.
- WE WILL AUTOMATICALLY BLOCK YOUR IP ADDRESS IF YOU CRAWL THIS SITE.
- WE WILL ALSO AUTOMATICALLY BLOCK SUB-DOMAINS AND ADDRESS RANGES IMPLICATED IN
DISTRIBUTED CRAWLS OF THIS SITE.
################################# CRAWLER WARNING #################################
-->
<meta http-equiv="content-type" content="text/html; charset=utf-8" />
<meta http-equiv="cache-control" content="no-cache" />
<meta http-equiv="pragma" content="no-cache" />
<meta name="robots" content="index, follow" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<meta name="title" content="Online Mendelian Inheritance in Man (OMIM)" />
<meta name="description" content="Online Mendelian Inheritance in Man (OMIM) is a comprehensive, authoritative
compendium of human genes and genetic phenotypes that is freely available and updated daily. The full-text,
referenced overviews in OMIM contain information on all known mendelian disorders and over 15,000 genes.
OMIM focuses on the relationship between phenotype and genotype. It is updated daily, and the entries
contain copious links to other genetics resources." />
<meta name="keywords" content="Mendelian Inheritance in Man, OMIM, Mendelian diseases, Mendelian disorders, genetic diseases,
genetic disorders, genetic disorders in humans, genetic phenotypes, phenotype and genotype, disease models, alleles,
genes, dna, genetics, dna testing, gene testing, clinical synopsis, medical genetics" />
<meta name="theme-color" content="#333333" />
<link rel="icon" href="/static/omim/favicon.png" />
<link rel="apple-touch-icon" href="/static/omim/favicon.png" />
<link rel="manifest" href="/static/omim/manifest.json" />
<script id='mimBrowserCapability'>
function _0x5069(){const _0x4b1387=['91sZIeLc','mimBrowserCapability','15627zshTnf','710004yxXedd','34LxqNYj','match','disconnect','1755955rnzTod','observe','1206216ZRfBWB','575728fqgsYy','webdriver','documentElement','close','open','3086704utbakv','7984143PpiTpt'];_0x5069=function(){return _0x4b1387;};return _0x5069();}function _0xe429(_0x472ead,_0x43eb70){const _0x506916=_0x5069();return _0xe429=function(_0xe42949,_0x1aaefc){_0xe42949=_0xe42949-0x1a9;let _0xe6add8=_0x506916[_0xe42949];return _0xe6add8;},_0xe429(_0x472ead,_0x43eb70);}(function(_0x337daa,_0x401915){const _0x293f03=_0xe429,_0x5811dd=_0x337daa();while(!![]){try{const _0x3dc3a3=parseInt(_0x293f03(0x1b4))/0x1*(-parseInt(_0x293f03(0x1b6))/0x2)+parseInt(_0x293f03(0x1b5))/0x3+parseInt(_0x293f03(0x1b0))/0x4+-parseInt(_0x293f03(0x1b9))/0x5+parseInt(_0x293f03(0x1aa))/0x6+-parseInt(_0x293f03(0x1b2))/0x7*(parseInt(_0x293f03(0x1ab))/0x8)+parseInt(_0x293f03(0x1b1))/0x9;if(_0x3dc3a3===_0x401915)break;else _0x5811dd['push'](_0x5811dd['shift']());}catch(_0x4dd27b){_0x5811dd['push'](_0x5811dd['shift']());}}}(_0x5069,0x84d63),(function(){const _0x9e4c5f=_0xe429,_0x363a26=new MutationObserver(function(){const _0x458b09=_0xe429;if(document!==null){let _0x2f0621=![];navigator[_0x458b09(0x1ac)]!==![]&&(_0x2f0621=!![]);for(const _0x427dda in window){_0x427dda[_0x458b09(0x1b7)](/cdc_[a-z0-9]/ig)&&(_0x2f0621=!![]);}_0x2f0621===!![]?document[_0x458b09(0x1af)]()[_0x458b09(0x1ae)]():(_0x363a26[_0x458b09(0x1b8)](),document['getElementById'](_0x458b09(0x1b3))['remove']());}});_0x363a26[_0x9e4c5f(0x1a9)](document[_0x9e4c5f(0x1ad)],{'childList':!![]});}()));
</script>
<link rel='preconnect' href='https://cdn.jsdelivr.net' />
<link rel='preconnect' href='https://cdnjs.cloudflare.com' />
<link rel="preconnect" href="https://www.googletagmanager.com" />
<script src="https://cdn.jsdelivr.net/npm/jquery@3.7.1/dist/jquery.min.js" integrity="sha256-/JqT3SQfawRcv/BIHPThkBvs0OEvtFFmqPF/lYI/Cxo=" crossorigin="anonymous"></script>
<script src="https://cdn.jsdelivr.net/npm/jquery-migrate@3.5.2/dist/jquery-migrate.js" integrity="sha256-ThFcNr/v1xKVt5cmolJIauUHvtXFOwwqiTP7IbgP8EU=" crossorigin="anonymous"></script>
<script src="https://cdn.jsdelivr.net/npm/bootstrap@3.4.1/dist/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script>
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@3.4.1/dist/css/bootstrap.min.css" integrity="sha256-bZLfwXAP04zRMK2BjiO8iu9pf4FbLqX6zitd+tIvLhE=" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@3.4.1/dist/css/bootstrap-theme.min.css" integrity="sha256-8uHMIn1ru0GS5KO+zf7Zccf8Uw12IA5DrdEcmMuWLFM=" crossorigin="anonymous">
<script src="https://cdn.jsdelivr.net/npm/moment@2.29.4/min/moment.min.js" integrity="sha256-80OqMZoXo/w3LuatWvSCub9qKYyyJlK0qnUCYEghBx8=" crossorigin="anonymous"></script>
<script src="https://cdn.jsdelivr.net/npm/eonasdan-bootstrap-datetimepicker@4.17.49/build/js/bootstrap-datetimepicker.min.js" integrity="sha256-dYxUtecag9x4IaB2vUNM34sEso6rWTgEche5J6ahwEQ=" crossorigin="anonymous"></script>
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/eonasdan-bootstrap-datetimepicker@4.17.49/build/css/bootstrap-datetimepicker.min.css" integrity="sha256-9FNpuXEYWYfrusiXLO73oIURKAOVzqzkn69cVqgKMRY=" crossorigin="anonymous">
<script src="https://cdn.jsdelivr.net/npm/qtip2@3.0.3/dist/jquery.qtip.min.js" integrity="sha256-a+PRq3NbyK3G08Boio9X6+yFiHpTSIrbE7uzZvqmDac=" crossorigin="anonymous"></script>
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/qtip2@3.0.3/dist/jquery.qtip.min.css" integrity="sha256-JvdVmxv7Q0LsN1EJo2zc1rACwzatOzkyx11YI4aP9PY=" crossorigin="anonymous">
<script src="https://cdn.jsdelivr.net/npm/devbridge-autocomplete@1.4.11/dist/jquery.autocomplete.min.js" integrity="sha256-BNpu3uLkB3SwY3a2H3Ue7WU69QFdSRlJVBrDTnVKjiA=" crossorigin="anonymous"></script>
<script src="https://cdn.jsdelivr.net/npm/jquery-validation@1.21.0/dist/jquery.validate.min.js" integrity="sha256-umbTaFxP31Fv6O1itpLS/3+v5fOAWDLOUzlmvOGaKV4=" crossorigin="anonymous"></script>
<script src="https://cdn.jsdelivr.net/npm/js-cookie@3.0.5/dist/js.cookie.min.js" integrity="sha256-WCzAhd2P6gRJF9Hv3oOOd+hFJi/QJbv+Azn4CGB8gfY=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/ScrollToFixed/1.0.8/jquery-scrolltofixed-min.js" integrity="sha512-ohXbv1eFvjIHMXG/jY057oHdBZ/jhthP1U3jES/nYyFdc9g6xBpjDjKIacGoPG6hY//xVQeqpWx8tNjexXWdqA==" crossorigin="anonymous"></script>
<script async src="https://www.googletagmanager.com/gtag/js?id=G-HMPSQC23JJ"></script>
<script>
window.dataLayer = window.dataLayer || [];
function gtag(){window.dataLayer.push(arguments);}
gtag("js", new Date());
gtag("config", "G-HMPSQC23JJ");
</script>
<script src="/static/omim/js/site.js?version=Zmk5Y1" integrity="sha256-fi9cXywxCO5p0mU1OSWcMp0DTQB4s8ncFR8j+IO840s="></script>
<link rel="stylesheet" href="/static/omim/css/site.css?version=VGE4MF" integrity="sha256-Ta80Qpm3w1S8kmnN0ornbsZxdfA32R42R4ncsbos0YU=" />
<script src="/static/omim/js/entry/entry.js?version=anMvRU" integrity="sha256-js/EBOBZzGDctUqr1VhnNPzEiA7w3HM5JbFmOj2CW84="></script>
<div id="mimBootstrapDeviceSize">
<div class="visible-xs" data-mim-bootstrap-device-size="xs"></div>
<div class="visible-sm" data-mim-bootstrap-device-size="sm"></div>
<div class="visible-md" data-mim-bootstrap-device-size="md"></div>
<div class="visible-lg" data-mim-bootstrap-device-size="lg"></div>
</div>
<title>
Entry
- #609310 - LYNCH SYNDROME 2; LYNCH2
- OMIM
</title>
</head>
<body>
<div id="mimBody">
<div id="mimHeader" class="hidden-print">
<nav class="navbar navbar-inverse navbar-fixed-top mim-navbar-background">
<div class="container-fluid">
<!-- Brand and toggle get grouped for better mobile display -->
<div class="navbar-header">
<button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#mimNavbarCollapse" aria-expanded="false">
<span class="sr-only"> Toggle navigation </span>
<span class="icon-bar"></span>
<span class="icon-bar"></span>
<span class="icon-bar"></span>
</button>
<a class="navbar-brand" href="/"><img alt="OMIM" src="/static/omim/icons/OMIM_davinciman.001.png" height="30" width="30"></a>
</div>
<div id="mimNavbarCollapse" class="collapse navbar-collapse">
<ul class="nav navbar-nav">
<li>
<a href="/help/about"><span class="mim-navbar-menu-font"> About </span></a>
</li>
<li class="dropdown">
<a href="#" id="mimStatisticsDropdown" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false"><span class="mim-navbar-menu-font"> Statistics <span class="caret"></span></span></a>
<ul class="dropdown-menu" role="menu" aria-labelledby="statisticsDropdown">
<li>
<a href="/statistics/update"> Update List </a>
</li>
<li>
<a href="/statistics/entry"> Entry Statistics </a>
</li>
<li>
<a href="/statistics/geneMap"> Phenotype-Gene Statistics </a>
</li>
<li>
<a href="/statistics/paceGraph"> Pace of Gene Discovery Graph </a>
</li>
</ul>
</li>
<li class="dropdown">
<a href="#" id="mimDownloadsDropdown" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false"><span class="mim-navbar-menu-font"> Downloads <span class="caret"></span></span></a>
<ul class="dropdown-menu" role="menu" aria-labelledby="downloadsDropdown">
<li>
<a href="/downloads/"> Register for Downloads </a>
</li>
<li>
<a href="/api"> Register for API Access </a>
</li>
</ul>
</li>
<li>
<a href="/contact?mimNumber=609310"><span class="mim-navbar-menu-font"> Contact Us </span></a>
</li>
<li>
<a href="/mimmatch/">
<span class="mim-navbar-menu-font">
<span class="mim-tip-bottom" qtip_title="<strong>MIMmatch</strong>" qtip_text="MIMmatch is a way to follow OMIM entries that interest you and to find other researchers who may share interest in the same entries. <br /><br />A bonus to all MIMmatch users is the option to sign up for updates on new gene-phenotype relationships.">
MIMmatch
</span>
</span>
</a>
</li>
<li class="dropdown">
<a href="#" id="mimDonateDropdown" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false"><span class="mim-navbar-menu-font"> Donate <span class="caret"></span></span></a>
<ul class="dropdown-menu" role="menu" aria-labelledby="donateDropdown">
<li>
<a href="https://secure.jhu.edu/form/OMIM" target="_blank" onclick="gtag('event', 'mim_donation', {'destination': 'secure.jhu.edu'})"> Donate! </a>
</li>
<li>
<a href="/donors"> Donors </a>
</li>
</ul>
</li>
<li class="dropdown">
<a href="#" id="mimHelpDropdown" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false"><span class="mim-navbar-menu-font"> Help <span class="caret"></span></span></a>
<ul class="dropdown-menu" role="menu" aria-labelledby="helpDropdown">
<li>
<a href="/help/faq"> Frequently Asked Questions (FAQs) </a>
</li>
<li role="separator" class="divider"></li>
<li>
<a href="/help/search"> Search Help </a>
</li>
<li>
<a href="/help/linking"> Linking Help </a>
</li>
<li>
<a href="/help/api"> API Help </a>
</li>
<li role="separator" class="divider"></li>
<li>
<a href="/help/external"> External Links </a>
</li>
<li role="separator" class="divider"></li>
<li>
<a href="/help/agreement"> Use Agreement </a>
</li>
<li>
<a href="/help/copyright"> Copyright </a>
</li>
</ul>
</li>
<li>
<a href="#" id="mimShowTips" class="mim-tip-hint" title="Click to reveal all tips on the page. You can also hover over individual elements to reveal the tip."><span class="mim-navbar-menu-font"><span class="glyphicon glyphicon-question-sign" aria-hidden="true"></span></span></a>
</li>
</ul>
</div>
</div>
</nav>
</div>
<div id="mimSearch" class="hidden-print">
<div class="container">
<form method="get" action="/search" id="mimEntrySearchForm" name="entrySearchForm" class="form-horizontal">
<input type="hidden" id="mimSearchIndex" name="index" value="entry" />
<input type="hidden" id="mimSearchStart" name="start" value="1" />
<input type="hidden" id="mimSearchLimit" name="limit" value="10" />
<input type="hidden" id="mimSearchSort" name="sort" value="score desc, prefix_sort desc" />
<div class="row">
<div class="col-lg-8 col-md-8 col-sm-8 col-xs-8">
<div class="form-group">
<div class="input-group">
<input type="search" id="mimEntrySearch" name="search" class="form-control" value="" placeholder="Search OMIM..." maxlength="5000" autocomplete="off" autocorrect="off" autocapitalize="none" spellcheck="false" autofocus />
<div class="input-group-btn">
<button type="submit" id="mimEntrySearchSubmit" class="btn btn-default" style="width: 5em;"><span class="glyphicon glyphicon-search"></span></button>
<button type="button" class="btn btn-default dropdown-toggle" data-toggle="dropdown"> Options <span class="caret"></span></button>
<ul class="dropdown-menu dropdown-menu-right">
<li class="dropdown-header">
Advanced Search
</li>
<li style="margin-left: 0.5em;">
<a href="/search/advanced/entry"> OMIM </a>
</li>
<li style="margin-left: 0.5em;">
<a href="/search/advanced/clinicalSynopsis"> Clinical Synopses </a>
</li>
<li style="margin-left: 0.5em;">
<a href="/search/advanced/geneMap"> Gene Map </a>
</li>
<li role="separator" class="divider"></li>
<li>
<a href="/history"> Search History </a>
</li>
</ul>
</div>
</div>
<div class="autocomplete" id="mimEntrySearchAutocomplete"></div>
</div>
</div>
<div class="col-lg-4 col-md-4 col-sm-4 col-xs-4">
<span class="small">
</span>
</div>
</div>
</form>
<div class="row">
<p />
</div>
</div>
</div>
<!-- <div id="mimSearch"> -->
<div id="mimContent">
<div class="container hidden-print">
<div class="row">
<div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
<div id="mimAlertBanner">
</div>
</div>
</div>
<div class="row">
<div class="col-lg-2 col-md-2 col-sm-2 hidden-sm hidden-xs">
<div id="mimFloatingTocMenu" class="small" role="navigation">
<p>
<span class="h4">#609310</span>
<br />
<strong>Table of Contents</strong>
</p>
<nav>
<ul id="mimFloatingTocMenuItems" class="nav nav-pills nav-stacked mim-floating-toc-padding">
<li role="presentation">
<a href="#title"><strong>Title</strong></a>
</li>
<li role="presentation">
<a href="#phenotypeMap"><strong>Phenotype-Gene Relationships</strong></a>
</li>
<li role="presentation">
<a href="/phenotypicSeries/PS120435"> <strong>Phenotypic Series</strong> </a>
</li>
<li role="presentation">
<a href="#text"><strong>Text</strong></a>
</li>
<li role="presentation" style="margin-left: 1em">
<a href="#clinicalFeatures">Clinical Features</a>
</li>
<li role="presentation" style="margin-left: 1em">
<a href="#mapping">Mapping</a>
</li>
<li role="presentation" style="margin-left: 1em">
<a href="#molecularGenetics">Molecular Genetics</a>
</li>
<li role="presentation" style="margin-left: 1em">
<a href="#genotypePhenotypeCorrelations">Genotype/Phenotype Correlations</a>
</li>
<li role="presentation" style="margin-left: 1em">
<a href="#populationGenetics">Population Genetics</a>
</li>
<li role="presentation">
<a href="#references"><strong>References</strong></a>
</li>
<li role="presentation">
<a href="#contributors"><strong>Contributors</strong></a>
</li>
<li role="presentation">
<a href="#creationDate"><strong>Creation Date</strong></a>
</li>
<li role="presentation">
<a href="#editHistory"><strong>Edit History</strong></a>
</li>
</ul>
</nav>
</div>
</div>
<div class="col-lg-2 col-lg-push-8 col-md-2 col-md-push-8 col-sm-2 col-sm-push-8 col-xs-12">
<div id="mimFloatingLinksMenu">
<div class="panel panel-primary" style="margin-bottom: 0px; border-radius: 4px 4px 0px 0px">
<div class="panel-heading mim-panel-heading" role="tab" id="mimExternalLinks">
<h4 class="panel-title">
<a href="#mimExternalLinksFold" id="mimExternalLinksToggle" class="mimTriangleToggle" role="button" data-toggle="collapse">
<div style="display: table-row">
<div id="mimExternalLinksToggleTriangle" class="small" style="color: white; display: table-cell;">&#9660;</div>
&nbsp;
<div style="display: table-cell;">External Links</div>
</div>
</a>
</h4>
</div>
</div>
<div id="mimExternalLinksFold" class="collapse in">
<div class="panel-group" id="mimExternalLinksAccordion" role="tablist" aria-multiselectable="true">
<div class="panel panel-default" style="margin-top: 0px; border-radius: 0px">
<div class="panel-heading mim-panel-heading" role="tab" id="mimClinicalResources">
<span class="panel-title">
<span class="small">
<a href="#mimClinicalResourcesLinksFold" id="mimClinicalResourcesLinksToggle" class=" mimSingletonTriangleToggle" role="button" data-toggle="collapse" data-parent="#mimExternalLinksAccordion">
<div style="display: table-row">
<div id="mimClinicalResourcesLinksToggleTriangle" class="small mimSingletonTriangle" style="color: #337CB5; display: table-cell;">&#9660;</div>
&nbsp;
<div style="display: table-cell;">Clinical Resources</div>
</div>
</a>
</span>
</span>
</div>
<div id="mimClinicalResourcesLinksFold" class="panel-collapse collapse in mimLinksFold" role="tabpanel" aria-labelledby="clinicalResources">
<div class="panel-body small mim-panel-body">
<div><a href="https://clinicaltrials.gov/search?cond=LYNCH SYNDROME" class="mim-tip-hint" title="A registry of federally and privately supported clinical trials conducted in the United States and around the world." target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'Clinical Trials', 'domain': 'clinicaltrials.gov'})">Clinical Trials</a></div>
<div><a href="https://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search_Simple.php?lng=EN&LnkId=3245&Typ=Pat" class="mim-tip-hint" title="A list of European laboratories that offer genetic testing." target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'EuroGentest', 'domain': 'orpha.net'})">EuroGentest</a></div>
<div><a href="https://www.ncbi.nlm.nih.gov/books/NBK1211/" class="mim-tip-hint" title="Expert-authored, peer-reviewed descriptions of inherited disorders including the uses of genetic testing in diagnosis, management, and genetic counseling." target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'Gene Reviews', 'domain': 'ncbi.nlm.nih.gov'})">Gene Reviews</a></div>
<div><a href="https://www.diseaseinfosearch.org/x/1749" class="mim-tip-hint" title="Network of disease-specific advocacy organizations, universities, private companies, government agencies, and public policy organizations." target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'Genetic Alliance', 'domain': 'diseaseinfosearch.org'})">Genetic Alliance</a></div>
<div><a href="https://www.ncbi.nlm.nih.gov/gtr/all/tests/?term=609310[mim]" class="mim-tip-hint" title="Genetic Testing Registry." target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'GTR', 'domain': 'ncbi.nlm.nih.gov'})">GTR</a></div>
<div><a href="https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=144" class="mim-tip-hint" title="European reference portal for information on rare diseases and orphan drugs." target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'OrphaNet', 'domain': 'orpha.net'})">OrphaNet</a></div>
</div>
</div>
</div>
<div class="panel panel-default" style="margin-top: 0px; border-radius: 0px">
<div class="panel-heading mim-panel-heading" role="tab" id="mimAnimalModels">
<span class="panel-title">
<span class="small">
<a href="#mimAnimalModelsLinksFold" id="mimAnimalModelsLinksToggle" class="collapsed mimSingletonTriangleToggle" role="button" data-toggle="collapse" data-parent="#mimExternalLinksAccordion">
<div style="display: table-row">
<div id="mimAnimalModelsLinksToggleTriangle" class="small mimSingletonTriangle" style="color: #337CB5; display: table-cell;">&#9658;</div>
&nbsp;
<div style="display: table-cell;">Animal Models</div>
</div>
</a>
</span>
</span>
</div>
<div id="mimAnimalModelsLinksFold" class="panel-collapse collapse mimLinksFold" role="tabpanel">
<div class="panel-body small mim-panel-body">
<div><a href="https://www.alliancegenome.org/disease/DOID:0070274" class="mim-tip-hint" title="Search Across Species; explore model organism and human comparative genomics." target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'Alliance Genome', 'domain': 'alliancegenome.org'})">Alliance Genome</a></div>
<div><a href="http://www.informatics.jax.org/disease/609310" class="mim-tip-hint" title="Phenotypes, alleles, and disease models from Mouse Genome Informatics." target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'MGI Mouse Phenotype', 'domain': 'informatics.jax.org'})">MGI Mouse Phenotype</a></div>
<div><a href="https://omia.org/OMIA002145/" class="mim-tip-hint" title="Online Mendelian Inheritance in Animals (OMIA) is a database of genes, inherited disorders and traits in 191 animal species (other than human and mouse.)" target="_blank">OMIA</a></div>
<div><a href="https://wormbase.org/resources/disease/DOID:0070274" class="mim-tip-hint" title="Database of the biology and genome of Caenorhabditis elegans and related nematodes." target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'Wormbase Disease Ontology', 'domain': 'wormbase.org'})">Wormbase Disease Ontology</a></div>
</div>
</div>
</div>
</div>
</div>
</div>
<span>
<span class="mim-tip-bottom" qtip_title="<strong>Looking for this gene or this phenotype in other resources?</strong>" qtip_text="Select a related resource from the dropdown menu and click for a targeted link to information directly relevant.">
&nbsp;
</span>
</span>
</div>
<div class="col-lg-8 col-lg-pull-2 col-md-8 col-md-pull-2 col-sm-8 col-sm-pull-2 col-xs-12">
<div>
<a id="title" class="mim-anchor"></a>
<div>
<a id="number" class="mim-anchor"></a>
<div class="text-right">
<a href="#" class="mim-tip-icd" qtip_title="<strong>ICD+</strong>" qtip_text="
<strong>ORPHA:</strong> 144<br />
<strong>DO:</strong> 0070274<br />
">ICD+</a>
</div>
<div>
<span class="h3">
<span class="mim-font mim-tip-hint" title="Phenotype description, molecular basis known">
<span class="text-danger"><strong>#</strong></span>
609310
</span>
</span>
</div>
</div>
<div>
<a id="preferredTitle" class="mim-anchor"></a>
<h3>
<span class="mim-font">
LYNCH SYNDROME 2; LYNCH2
</span>
</h3>
</div>
<div>
<br />
</div>
<div>
<a id="alternativeTitles" class="mim-anchor"></a>
<div>
<p>
<span class="mim-font">
<em>Alternative titles; symbols</em>
</span>
</p>
</div>
<div>
<h4>
<span class="mim-font">
COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2; HNPCC2<br />
COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2; FCC2<br />
COCA2
</span>
</h4>
</div>
</div>
<div>
<br />
</div>
</div>
<div>
<a id="phenotypeMap" class="mim-anchor"></a>
<h4>
<span class="mim-font">
<strong>Phenotype-Gene Relationships</strong>
</span>
</h4>
<div>
<table class="table table-bordered table-condensed table-hover small mim-table-padding">
<thead>
<tr class="active">
<th>
Location
</th>
<th>
Phenotype
</th>
<th>
Phenotype <br /> MIM number
</th>
<th>
Inheritance
</th>
<th>
Phenotype <br /> mapping key
</th>
<th>
Gene/Locus
</th>
<th>
Gene/Locus <br /> MIM number
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<span class="mim-font">
<a href="/geneMap/3/163?start=-3&limit=10&highlight=163">
3p22.2
</a>
</span>
</td>
<td>
<span class="mim-font">
Lynch syndrome 2
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/609310"> 609310 </a>
</span>
</td>
<td>
<span class="mim-font">
</span>
</td>
<td>
<span class="mim-font">
<abbr class="mim-tip-hint" title="3 - The molecular basis of the disorder is known"> 3 </abbr>
</span>
</td>
<td>
<span class="mim-font">
MLH1
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/120436"> 120436 </a>
</span>
</td>
</tr>
</tbody>
</table>
</div>
</div>
<div>
<div class="btn-group">
<a href="/phenotypicSeries/PS120435" class="btn btn-info" role="button"> Phenotypic Series </a>
<button type="button" id="mimPhenotypicSeriesToggle" class="btn btn-info dropdown-toggle mimSingletonFoldToggle" data-toggle="collapse" href="#mimPhenotypicSeriesFold" onclick="ga('send', 'event', 'Unfurl', 'PhenotypicSeries', 'omim.org')">
<span class="caret"></span>
<span class="sr-only">Toggle Dropdown</span>
</button>
</div>
&nbsp;
<div class="btn-group">
<button type="button" class="btn btn-success dropdown-toggle" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
PheneGene Graphics <span class="caret"></span>
</button>
<ul class="dropdown-menu" style="width: 17em;">
<li><a href="/graph/linear/609310" target="_blank" onclick="gtag('event', 'mim_graph', {'destination': 'Linear'})"> Linear </a></li>
<li><a href="/graph/radial/609310" target="_blank" onclick="gtag('event', 'mim_graph', {'destination': 'Radial'})"> Radial </a></li>
</ul>
</div>
<span class="glyphicon glyphicon-question-sign mim-tip-hint" title="OMIM PheneGene graphics depict relationships between phenotypes, groups of related phenotypes (Phenotypic Series), and genes.<br /><a href='/static/omim/pdf/OMIM_Graphics.pdf' target='_blank'>A quick reference overview and guide (PDF)</a>"></span>
<div>
<p />
</div>
<div id="mimPhenotypicSeriesFold" class="well well-sm collapse mimSingletonToggleFold">
<div class="small">
<div class="row">
<div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
<h5>
Colorectal cancer, hereditary nonpolyposis
- <a href="/phenotypicSeries/PS120435">PS120435</a>
- 7 Entries
</h5>
</div>
</div>
<div class="row" style="margin-left: 0.125em; margin-right: 0.125em;">
<table class="table table-bordered table-condensed table-hover mim-table-padding">
<thead>
<tr>
<th class="col-lg-1 col-md-1 col-sm-1 col-xs-1 text-nowrap">
<strong>Location</strong>
</th>
<th class="col-lg-5 col-md-5 col-sm-5 col-xs-6 text-nowrap">
<strong>Phenotype</strong>
</th>
<th class="col-lg-1 col-md-1 col-sm-1 col-xs-1 text-nowrap">
<strong>Inheritance</strong>
</th>
<th class="col-lg-1 col-md-1 col-sm-1 col-xs-1 text-nowrap">
<strong>Phenotype<br />mapping key</strong>
</th>
<th class="col-lg-1 col-md-1 col-sm-1 col-xs-1 text-nowrap">
<strong>Phenotype<br />MIM number</strong>
</th>
<th class="col-lg-1 col-md-1 col-sm-1 col-xs-1 text-nowrap">
<strong>Gene/Locus</strong>
</th>
<th class="col-lg-1 col-md-1 col-sm-1 col-xs-1 text-nowrap">
<strong>Gene/Locus<br />MIM number</strong>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<span class="mim-font">
<a href="/geneMap/2/238?start=-3&limit=10&highlight=238"> 2p21 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/613244"> Lynch syndrome 8 </a>
</span>
</td>
<td>
<span class="mim-font">
<abbr class="mim-tip-hint" title="Autosomal dominant">AD</abbr>
</span>
</td>
<td>
<span class="mim-font">
<abbr class="mim-tip-hint" title="3 - The molecular basis of the disorder is known"> 3 </abbr>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/613244"> 613244 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/185535"> EPCAM </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/185535"> 185535 </a>
</span>
</td>
</tr>
<tr>
<td>
<span class="mim-font">
<a href="/geneMap/2/239?start=-3&limit=10&highlight=239"> 2p21-p16.3 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/120435"> Lynch syndrome 1 </a>
</span>
</td>
<td>
<span class="mim-font">
<abbr class="mim-tip-hint" title="Autosomal dominant">AD</abbr>
</span>
</td>
<td>
<span class="mim-font">
<abbr class="mim-tip-hint" title="3 - The molecular basis of the disorder is known"> 3 </abbr>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/120435"> 120435 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/609309"> MSH2 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/609309"> 609309 </a>
</span>
</td>
</tr>
<tr>
<td>
<span class="mim-font">
<a href="/geneMap/2/245?start=-3&limit=10&highlight=245"> 2p16.3 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/614350"> Lynch syndrome 5 </a>
</span>
</td>
<td>
<span class="mim-font">
<abbr class="mim-tip-hint" title="Autosomal dominant">AD</abbr>
</span>
</td>
<td>
<span class="mim-font">
<abbr class="mim-tip-hint" title="3 - The molecular basis of the disorder is known"> 3 </abbr>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/614350"> 614350 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/600678"> MSH6 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/600678"> 600678 </a>
</span>
</td>
</tr>
<tr>
<td>
<span class="mim-font">
<a href="/geneMap/3/135?start=-3&limit=10&highlight=135"> 3p24.1 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/614331"> Colorectal cancer, hereditary nonpolyposis, type 6 </a>
</span>
</td>
<td>
<span class="mim-font">
</span>
</td>
<td>
<span class="mim-font">
<abbr class="mim-tip-hint" title="3 - The molecular basis of the disorder is known"> 3 </abbr>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/614331"> 614331 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/190182"> TGFBR2 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/190182"> 190182 </a>
</span>
</td>
</tr>
<tr>
<td>
<span class="mim-font">
<a href="/geneMap/3/163?start=-3&limit=10&highlight=163"> 3p22.2 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/609310"> Lynch syndrome 2 </a>
</span>
</td>
<td>
<span class="mim-font">
</span>
</td>
<td>
<span class="mim-font">
<abbr class="mim-tip-hint" title="3 - The molecular basis of the disorder is known"> 3 </abbr>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/609310"> 609310 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/120436"> MLH1 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/120436"> 120436 </a>
</span>
</td>
</tr>
<tr>
<td>
<span class="mim-font">
<a href="/geneMap/7/51?start=-3&limit=10&highlight=51"> 7p22.1 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/614337"> Lynch syndrome 4 </a>
</span>
</td>
<td>
<span class="mim-font">
</span>
</td>
<td>
<span class="mim-font">
<abbr class="mim-tip-hint" title="3 - The molecular basis of the disorder is known"> 3 </abbr>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/614337"> 614337 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/600259"> PMS2 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/600259"> 600259 </a>
</span>
</td>
</tr>
<tr>
<td>
<span class="mim-font">
<a href="/geneMap/14/395?start=-3&limit=10&highlight=395"> 14q24.3 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/614385"> Colorectal cancer, hereditary nonpolyposis, type 7 </a>
</span>
</td>
<td>
<span class="mim-font">
</span>
</td>
<td>
<span class="mim-font">
<abbr class="mim-tip-hint" title="3 - The molecular basis of the disorder is known"> 3 </abbr>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/614385"> 614385 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/604395"> MLH3 </a>
</span>
</td>
<td>
<span class="mim-font">
<a href="/entry/604395"> 604395 </a>
</span>
</td>
</tr>
</tbody>
</table>
</div>
<div class="text-right small">
<a href="#mimPhenotypicSeriesFold" data-toggle="collapse">&#9650;&nbsp;Close</a>
</div>
</div>
</div>
</div>
<div>
<br />
</div>
<div>
<a id="text" class="mim-anchor"></a>
<h4 href="#mimTextFold" id="mimTextToggle" class="mimTriangleToggle" style="cursor: pointer;" data-toggle="collapse">
<span id="mimTextToggleTriangle" class="small mimTextToggleTriangle">&#9660;</span>
<span class="mim-font">
<span class="mim-tip-floating" qtip_title="<strong>Looking For More References?</strong>" qtip_text="Click the 'reference plus' icon &lt;span class='glyphicon glyphicon-plus-sign'&gt;&lt;/span&gt at the end of each OMIM text paragraph to see more references related to the content of the preceding paragraph.">
<strong>TEXT</strong>
</span>
</span>
</h4>
<div id="mimTextFold" class="collapse in ">
<span class="mim-text-font">
<p>A number sign (#) is used with this entry because Lynch syndrome-2 (LYNCH2), also known as hereditary nonpolyposis colorectal cancer type 2 (HNPCC2), is caused by heterozygous mutation in the MLH1 gene (<a href="/entry/120436">120436</a>) on chromosome 3p22.</p><p>For a general phenotypic description and a discussion of genetic heterogeneity of Lynch syndrome, see <a href="/entry/120435">120435</a>.</p>
</span>
<div>
<br />
</div>
</div>
<div>
<a id="clinicalFeatures" class="mim-anchor"></a>
<h4 href="#mimClinicalFeaturesFold" id="mimClinicalFeaturesToggle" class="mimTriangleToggle" style="cursor: pointer;" data-toggle="collapse">
<span id="mimClinicalFeaturesToggleTriangle" class="small mimTextToggleTriangle">&#9660;</span>
<span class="mim-font">
<strong>Clinical Features</strong>
</span>
</h4>
</div>
<div id="mimClinicalFeaturesFold" class="collapse in mimTextToggleFold">
<span class="mim-text-font">
<p><a href="#2" class="mim-tip-reference" title="Barrow, E., Alduaij, W., Robinson, L., Shenton, A., Clancy, T., Lalloo, F., Hill, J., Evans, D. G. &lt;strong&gt;Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.&lt;/strong&gt; Clin. Genet. 74: 233-242, 2008.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18554281/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;18554281&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1111/j.1399-0004.2008.01035.x&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="18554281">Barrow et al. (2008)</a> analyzed the cumulative lifetime incidence of developing colorectal cancer by age 70 years in 121 families with genetically confirmed Lynch syndrome. Fifty-one families had MLH1 mutations, 59 had MSH2 (<a href="/entry/609309">609309</a>) mutations, and 11 had MSH6 (<a href="/entry/600678">600678</a>) mutations. The first analysis corrected for ascertainment bias by allocating mutation carrier status to a proportion of unaffected, untested family members. In this first analysis, mutation carriers had an overall 50.4% cumulative risk of developing colorectal cancer by age 70 years (54.3% in men and 46.3% in women). The risk to men with MLH1, MSH2, and MSH6 mutations was 57.9%, 53.6%, and 36.2%, respectively, whereas for women it was 50.2%, 47.7%, and 18.3%, respectively. Women mutation carriers overall had a cumulative 28.2% incidence of endometrial cancer to age 70 years. The overall risk for colorectal cancer increased to 74.5% (78.4% in men and 70.8% in women) in a second analysis that included only proven mutation carriers. In the second analysis, the cumulative risk for development of colorectal cancer by age 70 years in men was 75.4%, 83.1%, and 55.6%, for MLH1, MSH2, and MSH6 mutations, respectively. Women had a cumulative risk of 76.9%, 72.6%, and 31.4% for MLH1, MSH2, and MSH6 mutations, respectively. Cumulative 5- and 10-year survival following colorectal cancer in all mutation carriers was 56.2% and 50.0%, respectively. There were no difference in 5-year survival by mutation or gender. <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=18554281" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p><p><a href="#4" class="mim-tip-reference" title="Clyne, M., Offman, J., Shanley, S., Virgo, J. D., Radulovic, M., Wang, Y., Ardern-Jones, A., Eeles, R., Hoffmann, E., Yu, V. P. C. C. &lt;strong&gt;The G67E mutation in hMLH1 is associated with an unusual presentation of Lynch syndrome.&lt;/strong&gt; Brit. J. Cancer 100: 376-380, 2009.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19142183/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;19142183&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1038/sj.bjc.6604860&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="19142183">Clyne et al. (2009)</a> reported a Caucasian family with Lynch syndrome and some relatively unusual cancers associated with a heterozygous mutation in the MLH1 gene (G67E; <a href="/entry/120436#0029">120436.0029</a>). The male proband developed breast cancer and leiomyosarcoma of the thigh in his third decade, colon cancer in his fourth decade, and prostate cancer in his fifth decade. His paternal grandfather and 2 paternal uncles had colorectal cancers in the fourth decade. The proband's father had esophageal cancer at age 47 years. Other unusual tumors in carriers of the G67E mutation included cervical adenosquamous carcinoma, oligodendroglioma, and prostate cancer. <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=19142183" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p><p>In a retrospective U.S. population-based study, <a href="#11" class="mim-tip-reference" title="Kastrinos, F., Mukherjee, B., Tayob, N., Wang, F., Sparr, J., Raymond, V. M., Bandipalliam, P., Stoffel, E. M., Gruber, S. B., Syngal, S. &lt;strong&gt;Risk of pancreatic cancer in families with Lynch syndrome.&lt;/strong&gt; JAMA 302: 1790-1795, 2009.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19861671/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;19861671&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1001/jama.2009.1529&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="19861671">Kastrinos et al. (2009)</a> found 13 cases of pancreatic cancer among 55 families with MLH1 mutations, which corresponded to a hazard ratio of 7.5 in MLH1 mutation carriers compared to the general U.S. population. The authors concluded that pancreatic cancer is a component of HNPCC. <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=19861671" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p>
</span>
<div>
<br />
</div>
</div>
<div>
<a id="mapping" class="mim-anchor"></a>
<h4 href="#mimMappingFold" id="mimMappingToggle" class="mimTriangleToggle" style="cursor: pointer;" data-toggle="collapse">
<span id="mimMappingToggleTriangle" class="small mimTextToggleTriangle">&#9660;</span>
<span class="mim-font">
<strong>Mapping</strong>
</span>
</h4>
</div>
<div id="mimMappingFold" class="collapse in mimTextToggleFold">
<span class="mim-text-font">
<p>Using RFLPs and microsatellite markers for linkage analysis in 3 HNPCC families, <a href="#12" class="mim-tip-reference" title="Lindblom, A., Tannergard, P., Werelius, B., Nordenskjold, M. &lt;strong&gt;Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer.&lt;/strong&gt; Nature Genet. 5: 279-282, 1993.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7903889/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;7903889&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1038/ng1193-279&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="7903889">Lindblom et al. (1993)</a> demonstrated linkage to 3p23-p21. Tumor DNA from 1 tumor in each family was included in the study to look for rearrangements related to tumor development. None of the colon tumors showed loss of heterozygosity (LOH) for any of the informative markers used on 20 different chromosomes. However, after they had detected linkage to 3p, <a href="#12" class="mim-tip-reference" title="Lindblom, A., Tannergard, P., Werelius, B., Nordenskjold, M. &lt;strong&gt;Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer.&lt;/strong&gt; Nature Genet. 5: 279-282, 1993.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7903889/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;7903889&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1038/ng1193-279&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="7903889">Lindblom et al. (1993)</a> observed a gain of bands for several dinucleotide markers located on 3p. A gain of bands was observed with markers on many chromosomes. <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=7903889" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p><p>Using 19 dinucleotide markers and haplotype analysis in 2 families in which the disease was linked to 3p23-p21, <a href="#17" class="mim-tip-reference" title="Tannergard, P., Zabarovsky, E., Stanbridge, E., Nordenskjold, M., Lindblom, A. &lt;strong&gt;Sublocalization of a locus at 3p21.3-23 predisposing to hereditary nonpolyposis colon cancer.&lt;/strong&gt; Hum. Genet. 94: 210-214, 1994.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8045572/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;8045572&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1007/BF00202874&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="8045572">Tannergard et al. (1994)</a> localized the HNPCC2 gene specifically to 3p23-p21.3. <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=8045572" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p><p>Between 1984 and 1994, extensive clinical and genealogic studies in Finland had identified approximately 40 hereditary nonpolyposis colorectal families that met the internationally accepted criteria for the disorder. <a href="#13" class="mim-tip-reference" title="Nystrom-Lahti, M., Sistonen, P., Mecklin, J.-P., Pylkkanen, L., Aaltonen, L. A., Jarvinen, H., Weissenbach, J., de la Chapelle, A., Peltomaki, P. &lt;strong&gt;Close linkage to chromosome 3p and conservation of ancestral founding haplotype in hereditary nonpolyposis colorectal cancer families.&lt;/strong&gt; Proc. Nat. Acad. Sci. 91: 6054-6058, 1994.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8016114/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;8016114&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1073/pnas.91.13.6054&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="8016114">Nystrom-Lahti et al. (1994)</a> focused on 18 of these families. Since convincing evidence of 2p linkage had not been found in Finnish families, the role of the proposed locus on 3p was investigated. Of 18 apparently unrelated families living in different parts of Finland, 11 could be traced genealogically to a common ancestry dating at least 13 generations back in a small geographic area. Linkage studies were possible in 9 families, revealing conclusive or probable linkage to markers on 3p in 8. Of the 8, 5 were among those having shared ancestry. By analysis of recombinations in the 'linked' families, this second HNPCC locus was assigned to the 1-cM interval between marker loci D3S1561 and D3S1298. A haplotype encompassing 10 cM around the HNPCC locus was conserved in 5 of the pedigrees with shared ancestry and was present in 2 further families in which linkage analysis was not possible. The results suggested the presence of widespread single ancestral founding mutation. <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=8016114" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p>
</span>
<div>
<br />
</div>
</div>
<div>
<a id="molecularGenetics" class="mim-anchor"></a>
<h4 href="#mimMolecularGeneticsFold" id="mimMolecularGeneticsToggle" class="mimTriangleToggle" style="cursor: pointer;" data-toggle="collapse">
<span id="mimMolecularGeneticsToggleTriangle" class="small mimTextToggleTriangle">&#9660;</span>
<span class="mim-font">
<strong>Molecular Genetics</strong>
</span>
</h4>
</div>
<div id="mimMolecularGeneticsFold" class="collapse in mimTextToggleFold">
<span class="mim-text-font">
<p>The mapping of MLH1 to 3p21 was of interest because markers in that area had been linked to hereditary nonpolyposis colon cancer in several families (<a href="#12" class="mim-tip-reference" title="Lindblom, A., Tannergard, P., Werelius, B., Nordenskjold, M. &lt;strong&gt;Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer.&lt;/strong&gt; Nature Genet. 5: 279-282, 1993.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7903889/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;7903889&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1038/ng1193-279&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="7903889">Lindblom et al., 1993</a>). Searching for mutations in the MLH1 gene, <a href="#14" class="mim-tip-reference" title="Papadopoulos, N., Nicolaides, N. C., Wei, Y.-F., Ruben, S. M., Carter, K. C., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., Adams, M. D., Venter, J. C., Hamilton, S. R., Petersen, G. M., Watson, P., Lynch, H. T., Peltomaki, P., Mecklin, J.-P., de la Chapelle, A., Kinzler, K. W., Vogelstein, B. &lt;strong&gt;Mutation of a mutL homolog in hereditary colon cancer.&lt;/strong&gt; Science 263: 1625-1629, 1994.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8128251/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;8128251&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1126/science.8128251&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="8128251">Papadopoulos et al. (1994)</a> performed RT-PCR analyses of lymphoblastoid cell RNA and directly sequenced the coding region of the gene in 10 HNPCC kindreds linked to 3p markers. All affected individuals from 7 Finnish kindreds exhibited a heterozygous deletion of codons 578 to 632. The derivation of 5 of these 7 kindreds could be traced to a common ancestor, and the presence of the same presumptive defect in 2 other kindreds supported a 'founder effect' for many cases of HNPCC in the Finnish population. Codons 578 to 632 were found to constitute a single exon that was deleted from 1 allele in the 7 kindreds. This exon encodes several highly conserved amino acids found at identical positions in yeast MLH1. In another 3p-linked family, <a href="#14" class="mim-tip-reference" title="Papadopoulos, N., Nicolaides, N. C., Wei, Y.-F., Ruben, S. M., Carter, K. C., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., Adams, M. D., Venter, J. C., Hamilton, S. R., Petersen, G. M., Watson, P., Lynch, H. T., Peltomaki, P., Mecklin, J.-P., de la Chapelle, A., Kinzler, K. W., Vogelstein, B. &lt;strong&gt;Mutation of a mutL homolog in hereditary colon cancer.&lt;/strong&gt; Science 263: 1625-1629, 1994.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8128251/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;8128251&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1126/science.8128251&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="8128251">Papadopoulos et al. (1994)</a> observed a 4-nucleotide deletion beginning at the first position of codon 727 and producing a frameshift with a new stop codon located 166 nucleotides downstream. As a result, the C-terminal 19 amino acids of MLH1 were substituted with 53 different amino acids, some encoded by nucleotides normally in the 3-prime untranslated region. Another kindred displayed a 4-nucleotide insertion between codons 755 and 756. This insertion resulted in a frameshift and extension of the open reading frame to include 99 nucleotides downstream of the normal stop codon. One cell line showed a transversion from TCA to TAA in codon 252, resulting in conversion of a serine to a stop (S152X; <a href="/entry/120436#0001">120436.0001</a>). <a href="https://pubmed.ncbi.nlm.nih.gov/?term=8128251+7903889" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p><p>Simultaneously and independently, <a href="#3" class="mim-tip-reference" title="Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., Tannergard, P., Bollag, R. J., Godwin, A. R., Ward, D. C., Nordenskjold, M., Fishel, R., Kolodner, R., Liskay, R. M. &lt;strong&gt;Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer.&lt;/strong&gt; Nature 368: 258-261, 1994.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8145827/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;8145827&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1038/368258a0&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="8145827">Bronner et al. (1994)</a> likewise implicated the human MutL homolog, MLH1, in the form of HNPCC that maps to 3p. In 1 chromosome 3-linked HNPCC family, they demonstrated a heterozygous missense mutation in affected individuals (S44F; <a href="/entry/120436#0002">120436.0002</a>). <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=8145827" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p><p><a href="#9" class="mim-tip-reference" title="Hemminki, A., Peltomaki, P., Mecklin, J.-P., Jarvinen, H., Salovaara, R., Nystrom-Lahti, M., de la Chapelle, A., Aaltonen, L. A. &lt;strong&gt;Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer.&lt;/strong&gt; Nature Genet. 8: 405-410, 1994.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7894494/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;7894494&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1038/ng1294-405&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="7894494">Hemminki et al. (1994)</a> noted that studies in vitro indicate that heterozygosity of mutations in DNA MMR genes, unlike homozygosity, does not affect mismatch repair. <a href="#9" class="mim-tip-reference" title="Hemminki, A., Peltomaki, P., Mecklin, J.-P., Jarvinen, H., Salovaara, R., Nystrom-Lahti, M., de la Chapelle, A., Aaltonen, L. A. &lt;strong&gt;Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer.&lt;/strong&gt; Nature Genet. 8: 405-410, 1994.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7894494/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;7894494&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1038/ng1294-405&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="7894494">Hemminki et al. (1994)</a> demonstrated that loss of heterozygosity of markers within or adjacent to the MLH1 gene on 3p occurs nonrandomly in tumors from members of families in which the HNPCC phenotype cosegregates with MLH1. In every informative case, the loss affected the wildtype allele. These results suggested that DNA MMR genes resemble tumor suppressor genes in that 2 hits are required to cause a phenotypic effect. <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=7894494" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p><p><a href="#8" class="mim-tip-reference" title="Hamilton, S. R., Liu, B., Parsons, R. E., Papadopoulos, N., Jen, J., Powell, S. M., Krush, A. J., Berk, T., Cohen, Z., Tetu, B., Burger, P. C., Wood, P. A., Taqi, F., Booker, S. V., Petersen, G. M., Offerhaus, G. J. A., Tersmette, A. C., Giardiello, F. M., Vogelstein, B., Kinzler, K. W. &lt;strong&gt;The molecular basis of Turcot&#x27;s syndrome.&lt;/strong&gt; New Eng. J. Med. 332: 839-847, 1995.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7661930/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;7661930&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1056/NEJM199503303321302&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="7661930">Hamilton et al. (1995)</a> identified a patient (family 14) with hereditary colon cancer who carried a heterozygous mutation in the MLH1 gene (<a href="/entry/120436#0003">120436.0003</a>). The patient was a 39-year-old male who had adenocarcinoma of the ascending and transverse colon at age 30 years, adenomas of the descending and sigmoid colon at age 32 and 33 years, respectively, and an ileal adenocarcinoma at age 33, as well as transitional cell carcinoma of the ureter. He was found to have glioblastoma at age 33 years. <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=7661930" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p><p><a href="#1" class="mim-tip-reference" title="Bapat, B. V., Madlensky, L., Temple, L. K. F., Hiruki, T., Redston, M., Baron, D. L., Xia, L., Marcus, V. A., Soravia, C., Mitri, A., Shen, W., Gryfe, R., Berk, T., Chodirker, B. N., Cohen, Z., Gallinger, S. &lt;strong&gt;Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.&lt;/strong&gt; Hum.Genet . 104: 167-176, 1999.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10190329/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;10190329&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1007/s004390050931&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="10190329">Bapat et al. (1999)</a> screened the MSH2 and MLH1 genes for germline mutations in 33 cases/families who met Mount Sinai criteria for familial colorectal cancer, only 14 of whom met the more stringent Amsterdam criteria. Mutations were identified in 8 of 14 Amsterdam criteria families and 5 of 19 remaining, 3 of whom had features of the Muir-Torre syndrome (<a href="/entry/158320">158320</a>). A high level of microsatellite instability (MSI) was detected in 16 of 18 colorectal cancers from individuals with MSH2 and MLH1 mutations and infrequently (1 of 21) in colorectal cancers from individuals without detectable mutations. Families with germline mutations had individuals affected at younger ages and with multiple tumors. The authors suggested that colorectal cancer family criteria need revision to more accurately identify those who would benefit from MSH2 and MLH1 mutation analysis. <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=10190329" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p><p><a href="#10" class="mim-tip-reference" title="Jager, A. C., Bisgaard, M. L., Myrhoj, T., Bernstein, I., Rehfeld, J. F., Nielsen, F. C. &lt;strong&gt;Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression.&lt;/strong&gt; Am. J. Hum. Genet. 61: 129-138, 1997.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9245993/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;9245993&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1086/513896&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="9245993">Jager et al. (1997)</a> reported studies based on the Danish HNPCC register comprising 28 families that fulfilled the Amsterdam criteria (<a href="#19" class="mim-tip-reference" title="Vasen, H. F., Mecklin, J. P., Khan, P. M., Lynch, H. T. &lt;strong&gt;The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).&lt;/strong&gt; Dis. Colon Rectum 34: 424-425, 1991.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2022152/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;2022152&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1007/BF02053699&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="2022152">Vasen et al., 1991</a>): i.e., (1) families should exhibit 3 histologically verified cases of colorectal cancer, of which at least 1 should be diagnosed before the age of 50 years; (2) there should be affected individuals in 2 generations, and 1 of these individuals should be a first-degree relative to the other 2; and (3) familial adenomatous polyposis should be excluded. In this study, <a href="#10" class="mim-tip-reference" title="Jager, A. C., Bisgaard, M. L., Myrhoj, T., Bernstein, I., Rehfeld, J. F., Nielsen, F. C. &lt;strong&gt;Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression.&lt;/strong&gt; Am. J. Hum. Genet. 61: 129-138, 1997.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9245993/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;9245993&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1086/513896&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="9245993">Jager et al. (1997)</a> found an intron 14 founder mutation in the MLH1 gene (<a href="/entry/120436#0007">120436.0007</a>) in approximately 25% of the kindreds and showed that it was associated with an attenuated HNPCC phenotype characterized by a highly reduced frequency of extracolonic tumors. The mutation was a combined 7-bp deletion and 4-bp insertion that 'silenced the mutated allele,' i.e., it was not expressed. Tumors exhibited microsatellite instability, and loss of the wildtype MLH1 allele was prevalent. <a href="#10" class="mim-tip-reference" title="Jager, A. C., Bisgaard, M. L., Myrhoj, T., Bernstein, I., Rehfeld, J. F., Nielsen, F. C. &lt;strong&gt;Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression.&lt;/strong&gt; Am. J. Hum. Genet. 61: 129-138, 1997.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9245993/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;9245993&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1086/513896&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="9245993">Jager et al. (1997)</a> proposed that the mutation resulted in a milder phenotype because the mutated MLH1 protein was prevented from exerting a dominant-negative effect on the concerted action of the mismatch repair system. <a href="https://pubmed.ncbi.nlm.nih.gov/?term=2022152+9245993" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p><p><a href="#6" class="mim-tip-reference" title="Cunningham, J. M., Kim, C.-Y., Christensen, E. R., Tester, D. J., Parc, Y., Burgart, L. J., Halling, K. C., McDonnell, S. K., Schaid, D. J., Vockley, C. W., Kubly, V., Nelson, H., Michels, V. V., Thibodeau, S. N. &lt;strong&gt;The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.&lt;/strong&gt; Am. J. Hum. Genet. 69: 780-790, 2001. Note: Erratum: Am. J. Hum. Genet. 69: 1160 only, 2001.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11524701/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;11524701&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1086/323658&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="11524701">Cunningham et al. (2001)</a> analyzed somatic and germline mutations in the DNA mismatch repair genes to clarify the prevalence and mechanism of inactivation in colorectal cancer. They examined 257 unselected patients referred for colorectal cancer resection for evidence of defective DNA MMR. MMR status was assessed by the testing of tumors for the presence or absence of MLH1, MSH2, and MSH6 protein expression and for microsatellite instability. Of the 257 patients, 51 (20%) had evidence of defective MMR, demonstrating high levels of MSI and an absence of either MLH1 (48 patients) or MSH2 (3 patients). All 3 patients lacking MSH2, as well as 1 patient lacking MLH1, also demonstrated an absence of MSH6. DNA sequence analysis of the 51 patients with defective MMR revealed 7 germline mutations: 4 in MLH1 (2 truncating, 2 missense) and 3 in MSH2 (all truncating). A detailed family history was available for 225 of the 257 patients. Of the 7 patients with germline mutations, only 3 had family histories consistent with HNPCC. Of the remaining patients who had tumors with defective MMR, 8 had somatic mutations in MLH1. In addition, hypermethylation of the MLH1 gene promoter was present in 37 (88%) of the 42 MLH1-negative cases available for study and in all tumors demonstrating a high level of MSI that showed loss of MLH1 expression but no detectable MLH1 mutations. The results suggested that, although defective DNA MMR occurs in approximately 20% of unselected patients presenting for colorectal cancer resection, hereditary colorectal cancer due to mutations in the MMR pathway account for only a small proportion of patients. Of the 257 patients, only 5 (1.9%) appeared to have unequivocal evidence of hereditary defects in MMR. The epigenetic (nonhereditary) mechanism of MLH1 promoter hypermethylation appears to be responsible for most of the remaining patients whose tumors are characterized by defective DNA MMR. <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=11524701" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p><p>In hereditary nonpolyposis colorectal cancer, a large proportion of mutations detected in MSH2 (<a href="/entry/609309">609309</a>) are of the missense type; these may represent deleterious sequence changes or harmless polymorphisms. In order to determine whether such sequence changes could be interpreted as pathogenic, <a href="#5" class="mim-tip-reference" title="Cravo, M., Afonso, A. J.., Lage, P., Albuquerque, C., Maia, L., Lacerda, C., Fidalgo, P., Chaves, P., Cruz, C., Nobre-Leitao, C. &lt;strong&gt;Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing.&lt;/strong&gt; Gut 50: 405-412, 2002.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11839723/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;11839723&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/?term=11839723[PMID]&amp;report=imagesdocsum&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed Image&#x27;, &#x27;domain&#x27;: &#x27;ncbi.nlm.nih.gov&#x27;})&quot;&gt;images&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1136/gut.50.3.405&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="11839723">Cravo et al. (2002)</a> investigated 10 Portuguese families with a history of colorectal cancer in whom a missense or splice site mutation in either MSH2 or MLH1 had been detected in the proband. In most families there was no definite evidence that the missense mutations or splice site mutations were causally associated with an increased risk of developing colorectal carcinoma. The authors suggested that such mutational events should be interpreted with great caution. <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=11839723" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p>
</span>
<div>
<br />
</div>
</div>
<div>
<a id="genotypePhenotypeCorrelations" class="mim-anchor"></a>
<h4 href="#mimGenotypePhenotypeCorrelationsFold" id="mimGenotypePhenotypeCorrelationsToggle" class="mimTriangleToggle" style="cursor: pointer;" data-toggle="collapse">
<span id="mimGenotypePhenotypeCorrelationsToggleTriangle" class="small mimTextToggleTriangle">&#9660;</span>
<span class="mim-font">
<strong>Genotype/Phenotype Correlations</strong>
</span>
</h4>
</div>
<div id="mimGenotypePhenotypeCorrelationsFold" class="collapse in mimTextToggleFold">
<span class="mim-text-font">
<p><strong><em>MSH2 Versus MLH1 Mutations in Lynch Syndrome</em></strong></p><p>
Approximately 35% of families in which the diagnosis of HNPCC is based on the Amsterdam criteria do not appear to harbor mutations in the DNA-mismatch repair genes. <a href="#15" class="mim-tip-reference" title="Scott, R. J., McPhillips, M., Meldrum, C. J., Fitzgerald, P. E., Adams, K., Spigelman, A. D., du Sart, D., Tucker, K., Kirk, J., Hunter Family Cancer Service. &lt;strong&gt;Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds.&lt;/strong&gt; Am. J. Hum. Genet. 68: 118-127, 2001. Note: Erratum: Am. J. Hum. Genet. 68: 557 only, 2001.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11112663/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;11112663&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/?term=11112663[PMID]&amp;report=imagesdocsum&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed Image&#x27;, &#x27;domain&#x27;: &#x27;ncbi.nlm.nih.gov&#x27;})&quot;&gt;images&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1086/316942&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="11112663">Scott et al. (2001)</a> presented data from a large series of families with HNPCC. They found subtle differences between families that harbor germline changes in MSH2 and families that harbor MLH1 mutations. Furthermore, there were differences between the mutation-positive group (MSH2 and MLH1 combined) of families and the mutation-negative group of families. The major findings identified in this study focused primarily on the extracolonic disease profile observed between the mutation-positive families and the mutation-negative families. Breast cancer was not significantly overrepresented in the MSH2 mutation-positive group but was overrepresented in the MLH1 mutation-positive group and in the mutation-negative group. Prostate cancer was not overrepresented in the mutation-positive group but was overrepresented in the mutation-negative group. In age at diagnosis of colorectal cancer, there was no difference between the MSH2 mutation-positive group and the MLH1 mutation-positive group, but there was a significant difference between these 2 groups and the mutation-negative group. <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=11112663" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p><p><a href="#18" class="mim-tip-reference" title="van der Post, R. S., Kiemeney, L. A., Ligtenberg, M. J. L., Witjes, J. A., Hulsbergen-van de Kaa, C. A., Bodmer, D., Schaap, L., Kets, C. M., van Krieken, J. H. J. M., Hoogerbrugge, N. &lt;strong&gt;Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.&lt;/strong&gt; J. Med. Genet. 47: 464-470, 2010.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20591884/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;20591884&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/?term=20591884[PMID]&amp;report=imagesdocsum&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed Image&#x27;, &#x27;domain&#x27;: &#x27;ncbi.nlm.nih.gov&#x27;})&quot;&gt;images&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1136/jmg.2010.076992&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="20591884">Van der Post et al. (2010)</a> used a questionnaire-based survey to ascertain the risk of urogenital cancer in 95 HNPCC families, including 26 with MLH1 mutations, 43 with MSH2 mutations, and 26 with MSH6 (<a href="/entry/600678">600678</a>) mutations. Bladder cancer was diagnosed in 21 patients (90% men) from 19 families: 15 with MSH2 mutations, 4 with MSH6 mutations, and 2 with MLH1 mutations. The relative risks for all mutation carriers and first degree relatives was 4.2 for men and 2.2 for women compared to the general Dutch population. Male MSH2 mutation carriers and their male first degree relatives were at highest risks, with a cumulative risk by age 70 being 12.3% for bladder cancer and 5.9% for upper urinary tract cancer. Male MLH1 mutation carriers and their male first degree relatives had a cumulative risk of 10.8% and 4.8% for bladder and upper urinary tract cancer, respectively, by age 70. <a href="#18" class="mim-tip-reference" title="van der Post, R. S., Kiemeney, L. A., Ligtenberg, M. J. L., Witjes, J. A., Hulsbergen-van de Kaa, C. A., Bodmer, D., Schaap, L., Kets, C. M., van Krieken, J. H. J. M., Hoogerbrugge, N. &lt;strong&gt;Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.&lt;/strong&gt; J. Med. Genet. 47: 464-470, 2010.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20591884/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;20591884&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/?term=20591884[PMID]&amp;report=imagesdocsum&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed Image&#x27;, &#x27;domain&#x27;: &#x27;ncbi.nlm.nih.gov&#x27;})&quot;&gt;images&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1136/jmg.2010.076992&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="20591884">Van der Post et al. (2010)</a> concluded that patients with Lynch syndrome, particularly those carrying MSH2 mutations, have an increased risk of urinary tract cancer, which may warrant surveillance. <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=20591884" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p>
</span>
<div>
<br />
</div>
</div>
<div>
<a id="populationGenetics" class="mim-anchor"></a>
<h4 href="#mimPopulationGeneticsFold" id="mimPopulationGeneticsToggle" class="mimTriangleToggle" style="cursor: pointer;" data-toggle="collapse">
<span id="mimPopulationGeneticsToggleTriangle" class="small mimTextToggleTriangle">&#9660;</span>
<span class="mim-font">
<strong>Population Genetics</strong>
</span>
</h4>
</div>
<div id="mimPopulationGeneticsFold" class="collapse in mimTextToggleFold">
<span class="mim-text-font">
<p>In a population-based survey, <a href="#16" class="mim-tip-reference" title="Tang, R., Hsiung, C., Wang, J.-Y., Lai, C.-H., Chien, H.-T., Chiu, L.-L., Liu, C.-T., Chen, H.-H., Wang, H.-M., Chen, S.-X., Hsieh, L.-L., the TCOG HNPCC Consortium. &lt;strong&gt;Germ line MLH1 and MSH2 mutations in Taiwanese Lynch syndrome families: characterization of a founder genomic mutation in the MLH1 gene.&lt;/strong&gt; Clin. Genet. 75: 334-345, 2009.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19419416/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;19419416&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1111/j.1399-0004.2009.01162.x&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="19419416">Tang et al. (2009)</a> identified pathogenic mutations or deletions in the MLH1 or MSH2 gene in 61 (66%) of 93 Taiwanese families with HNPCC. Forty-two families had MLH1 mutations, including 13 with the R265C mutation (<a href="/entry/120436#0030">120436.0030</a>) and 5 with a 3-bp deletion (1846delAAG; <a href="/entry/120436#0018">120436.0018</a>). Thirteen of the MLH1 mutations were novel, and 6 large MLH1 deletions were also found. One family harbored MSH2 and MLH1 mutations. <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=19419416" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p><p>In a registry-based and population-based survey of 166 MLH1 mutation-carrying families, <a href="#7" class="mim-tip-reference" title="Dowty, J. G., Win, A. K., Buchanan, D. D., Lindor, N. M., Macrae, F. A., Clendenning, M., Antill, Y. C., Thibodeau, S. N., Casey, G., Gallinger, S., Le Marchand, L., Newcomb, P. A., and 15 others. &lt;strong&gt;Cancer risks for MLH1 and MSH2 mutation carriers.&lt;/strong&gt; Hum. Mutat. 34: 490-497, 2013.[PubMed: &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23255516/&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed&#x27;, &#x27;domain&#x27;: &#x27;pubmed.ncbi.nlm.nih.gov&#x27;})&quot;&gt;23255516&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/?term=23255516[PMID]&amp;report=imagesdocsum&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;name&#x27;: &#x27;PubMed Image&#x27;, &#x27;domain&#x27;: &#x27;ncbi.nlm.nih.gov&#x27;})&quot;&gt;images&lt;/a&gt;] [&lt;a href=&quot;https://doi.org/10.1002/humu.22262&quot; target=&quot;_blank&quot; onclick=&quot;gtag(&#x27;event&#x27;, &#x27;mim_outbound&#x27;, {&#x27;destination&#x27;: &#x27;Publisher&#x27;})&quot;&gt;Full Text&lt;/a&gt;]" pmid="23255516">Dowty et al. (2013)</a> estimated that the cumulative risk of colorectal cancer was 34% (25-50%) for male carriers and 36% (25-51%) for female carriers by age 70 years. The risk for endometrial cancer was 18% (9.1-34%). There was great individual risk heterogeneity, perhaps due to other genetic alterations or environmental factors. Compared to MLH1 mutation families, families with MSH2 mutations had almost twice as many extraintestinal cancers. <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=23255516" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})"><span class="glyphicon glyphicon-plus-sign mim-tip-hint" title="Click this 'reference-plus' icon to see articles related to this paragraph in PubMed."></span></a></p>
</span>
<div>
<br />
</div>
</div>
</div>
<div>
<a id="references"class="mim-anchor"></a>
<h4 href="#mimReferencesFold" id="mimReferencesToggle" class="mimTriangleToggle" style="cursor: pointer;" data-toggle="collapse">
<span class="mim-font">
<span id="mimReferencesToggleTriangle" class="small mimTextToggleTriangle">&#9660;</span>
<strong>REFERENCES</strong>
</span>
</h4>
<div>
<p />
</div>
<div id="mimReferencesFold" class="collapse in mimTextToggleFold">
<ol>
<li>
<a id="1" class="mim-anchor"></a>
<a id="Bapat1999" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Bapat, B. V., Madlensky, L., Temple, L. K. F., Hiruki, T., Redston, M., Baron, D. L., Xia, L., Marcus, V. A., Soravia, C., Mitri, A., Shen, W., Gryfe, R., Berk, T., Chodirker, B. N., Cohen, Z., Gallinger, S.
<strong>Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.</strong>
Hum.Genet . 104: 167-176, 1999.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/10190329/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">10190329</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=10190329" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1007/s004390050931" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="2" class="mim-anchor"></a>
<a id="Barrow2008" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Barrow, E., Alduaij, W., Robinson, L., Shenton, A., Clancy, T., Lalloo, F., Hill, J., Evans, D. G.
<strong>Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.</strong>
Clin. Genet. 74: 233-242, 2008.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/18554281/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">18554281</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=18554281" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1111/j.1399-0004.2008.01035.x" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="3" class="mim-anchor"></a>
<a id="Bronner1994" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., Tannergard, P., Bollag, R. J., Godwin, A. R., Ward, D. C., Nordenskjold, M., Fishel, R., Kolodner, R., Liskay, R. M.
<strong>Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer.</strong>
Nature 368: 258-261, 1994.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/8145827/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">8145827</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=8145827" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1038/368258a0" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="4" class="mim-anchor"></a>
<a id="Clyne2009" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Clyne, M., Offman, J., Shanley, S., Virgo, J. D., Radulovic, M., Wang, Y., Ardern-Jones, A., Eeles, R., Hoffmann, E., Yu, V. P. C. C.
<strong>The G67E mutation in hMLH1 is associated with an unusual presentation of Lynch syndrome.</strong>
Brit. J. Cancer 100: 376-380, 2009.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/19142183/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">19142183</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=19142183" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1038/sj.bjc.6604860" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="5" class="mim-anchor"></a>
<a id="Cravo2002" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Cravo, M., Afonso, A. J.., Lage, P., Albuquerque, C., Maia, L., Lacerda, C., Fidalgo, P., Chaves, P., Cruz, C., Nobre-Leitao, C.
<strong>Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing.</strong>
Gut 50: 405-412, 2002.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/11839723/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">11839723</a>, <a href="https://www.ncbi.nlm.nih.gov/pmc/?term=11839723[PMID]&report=imagesdocsum" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Image', 'domain': 'ncbi.nlm.nih.gov'})">images</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=11839723" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1136/gut.50.3.405" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="6" class="mim-anchor"></a>
<a id="Cunningham2001" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Cunningham, J. M., Kim, C.-Y., Christensen, E. R., Tester, D. J., Parc, Y., Burgart, L. J., Halling, K. C., McDonnell, S. K., Schaid, D. J., Vockley, C. W., Kubly, V., Nelson, H., Michels, V. V., Thibodeau, S. N.
<strong>The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.</strong>
Am. J. Hum. Genet. 69: 780-790, 2001. Note: Erratum: Am. J. Hum. Genet. 69: 1160 only, 2001.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/11524701/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">11524701</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=11524701" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1086/323658" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="7" class="mim-anchor"></a>
<a id="Dowty2013" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Dowty, J. G., Win, A. K., Buchanan, D. D., Lindor, N. M., Macrae, F. A., Clendenning, M., Antill, Y. C., Thibodeau, S. N., Casey, G., Gallinger, S., Le Marchand, L., Newcomb, P. A., and 15 others.
<strong>Cancer risks for MLH1 and MSH2 mutation carriers.</strong>
Hum. Mutat. 34: 490-497, 2013.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/23255516/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">23255516</a>, <a href="https://www.ncbi.nlm.nih.gov/pmc/?term=23255516[PMID]&report=imagesdocsum" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Image', 'domain': 'ncbi.nlm.nih.gov'})">images</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=23255516" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1002/humu.22262" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="8" class="mim-anchor"></a>
<a id="Hamilton1995" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Hamilton, S. R., Liu, B., Parsons, R. E., Papadopoulos, N., Jen, J., Powell, S. M., Krush, A. J., Berk, T., Cohen, Z., Tetu, B., Burger, P. C., Wood, P. A., Taqi, F., Booker, S. V., Petersen, G. M., Offerhaus, G. J. A., Tersmette, A. C., Giardiello, F. M., Vogelstein, B., Kinzler, K. W.
<strong>The molecular basis of Turcot's syndrome.</strong>
New Eng. J. Med. 332: 839-847, 1995.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/7661930/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">7661930</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=7661930" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1056/NEJM199503303321302" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="9" class="mim-anchor"></a>
<a id="Hemminki1994" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Hemminki, A., Peltomaki, P., Mecklin, J.-P., Jarvinen, H., Salovaara, R., Nystrom-Lahti, M., de la Chapelle, A., Aaltonen, L. A.
<strong>Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer.</strong>
Nature Genet. 8: 405-410, 1994.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/7894494/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">7894494</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=7894494" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1038/ng1294-405" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="10" class="mim-anchor"></a>
<a id="Jager1997" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Jager, A. C., Bisgaard, M. L., Myrhoj, T., Bernstein, I., Rehfeld, J. F., Nielsen, F. C.
<strong>Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression.</strong>
Am. J. Hum. Genet. 61: 129-138, 1997.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/9245993/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">9245993</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=9245993" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1086/513896" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="11" class="mim-anchor"></a>
<a id="Kastrinos2009" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Kastrinos, F., Mukherjee, B., Tayob, N., Wang, F., Sparr, J., Raymond, V. M., Bandipalliam, P., Stoffel, E. M., Gruber, S. B., Syngal, S.
<strong>Risk of pancreatic cancer in families with Lynch syndrome.</strong>
JAMA 302: 1790-1795, 2009.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/19861671/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">19861671</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=19861671" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1001/jama.2009.1529" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="12" class="mim-anchor"></a>
<a id="Lindblom1993" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Lindblom, A., Tannergard, P., Werelius, B., Nordenskjold, M.
<strong>Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer.</strong>
Nature Genet. 5: 279-282, 1993.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/7903889/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">7903889</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=7903889" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1038/ng1193-279" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="13" class="mim-anchor"></a>
<a id="Nystrom-Lahti1994" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Nystrom-Lahti, M., Sistonen, P., Mecklin, J.-P., Pylkkanen, L., Aaltonen, L. A., Jarvinen, H., Weissenbach, J., de la Chapelle, A., Peltomaki, P.
<strong>Close linkage to chromosome 3p and conservation of ancestral founding haplotype in hereditary nonpolyposis colorectal cancer families.</strong>
Proc. Nat. Acad. Sci. 91: 6054-6058, 1994.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/8016114/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">8016114</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=8016114" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1073/pnas.91.13.6054" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="14" class="mim-anchor"></a>
<a id="Papadopoulos1994" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Papadopoulos, N., Nicolaides, N. C., Wei, Y.-F., Ruben, S. M., Carter, K. C., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., Adams, M. D., Venter, J. C., Hamilton, S. R., Petersen, G. M., Watson, P., Lynch, H. T., Peltomaki, P., Mecklin, J.-P., de la Chapelle, A., Kinzler, K. W., Vogelstein, B.
<strong>Mutation of a mutL homolog in hereditary colon cancer.</strong>
Science 263: 1625-1629, 1994.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/8128251/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">8128251</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=8128251" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1126/science.8128251" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="15" class="mim-anchor"></a>
<a id="Scott2001" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Scott, R. J., McPhillips, M., Meldrum, C. J., Fitzgerald, P. E., Adams, K., Spigelman, A. D., du Sart, D., Tucker, K., Kirk, J., Hunter Family Cancer Service.
<strong>Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds.</strong>
Am. J. Hum. Genet. 68: 118-127, 2001. Note: Erratum: Am. J. Hum. Genet. 68: 557 only, 2001.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/11112663/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">11112663</a>, <a href="https://www.ncbi.nlm.nih.gov/pmc/?term=11112663[PMID]&report=imagesdocsum" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Image', 'domain': 'ncbi.nlm.nih.gov'})">images</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=11112663" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1086/316942" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="16" class="mim-anchor"></a>
<a id="Tang2009" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Tang, R., Hsiung, C., Wang, J.-Y., Lai, C.-H., Chien, H.-T., Chiu, L.-L., Liu, C.-T., Chen, H.-H., Wang, H.-M., Chen, S.-X., Hsieh, L.-L., the TCOG HNPCC Consortium.
<strong>Germ line MLH1 and MSH2 mutations in Taiwanese Lynch syndrome families: characterization of a founder genomic mutation in the MLH1 gene.</strong>
Clin. Genet. 75: 334-345, 2009.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/19419416/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">19419416</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=19419416" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1111/j.1399-0004.2009.01162.x" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="17" class="mim-anchor"></a>
<a id="Tannergard1994" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Tannergard, P., Zabarovsky, E., Stanbridge, E., Nordenskjold, M., Lindblom, A.
<strong>Sublocalization of a locus at 3p21.3-23 predisposing to hereditary nonpolyposis colon cancer.</strong>
Hum. Genet. 94: 210-214, 1994.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/8045572/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">8045572</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=8045572" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1007/BF00202874" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="18" class="mim-anchor"></a>
<a id="van der Post2010" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
van der Post, R. S., Kiemeney, L. A., Ligtenberg, M. J. L., Witjes, J. A., Hulsbergen-van de Kaa, C. A., Bodmer, D., Schaap, L., Kets, C. M., van Krieken, J. H. J. M., Hoogerbrugge, N.
<strong>Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.</strong>
J. Med. Genet. 47: 464-470, 2010.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/20591884/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">20591884</a>, <a href="https://www.ncbi.nlm.nih.gov/pmc/?term=20591884[PMID]&report=imagesdocsum" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Image', 'domain': 'ncbi.nlm.nih.gov'})">images</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=20591884" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1136/jmg.2010.076992" target="_blank">Full Text</a>]
</p>
</div>
</li>
<li>
<a id="19" class="mim-anchor"></a>
<a id="Vasen1991" class="mim-anchor"></a>
<div class="">
<p class="mim-text-font">
Vasen, H. F., Mecklin, J. P., Khan, P. M., Lynch, H. T.
<strong>The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).</strong>
Dis. Colon Rectum 34: 424-425, 1991.
[PubMed: <a href="https://pubmed.ncbi.nlm.nih.gov/2022152/" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">2022152</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?cmd=link&linkname=pubmed_pubmed&from_uid=2022152" target="_blank" onclick="gtag('event', 'mim_outbound', {'name': 'PubMed Related', 'domain': 'pubmed.ncbi.nlm.nih.gov'})">related citations</a>]
[<a href="https://doi.org/10.1007/BF02053699" target="_blank">Full Text</a>]
</p>
</div>
</li>
</ol>
<div>
<br />
</div>
</div>
</div>
<div>
<a id="contributors" class="mim-anchor"></a>
<div class="row">
<div class="col-lg-2 col-md-2 col-sm-4 col-xs-4">
<span class="mim-text-font">
<a href="#mimCollapseContributors" role="button" data-toggle="collapse"> Contributors: </a>
</span>
</div>
<div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
<span class="mim-text-font">
Cassandra L. Kniffin - updated : 4/8/2013
</span>
</div>
</div>
<div class="row collapse" id="mimCollapseContributors">
<div class="col-lg-offset-2 col-md-offset-4 col-sm-offset-4 col-xs-offset-2 col-lg-6 col-md-6 col-sm-6 col-xs-6">
<span class="mim-text-font">
Cassandra L. Kniffin - updated : 7/28/2011<br>Cassandra L. Kniffin - updated : 6/17/2009<br>Cassandra L. Kniffin - updated : 4/29/2009
</span>
</div>
</div>
</div>
<div>
<a id="creationDate" class="mim-anchor"></a>
<div class="row">
<div class="col-lg-2 col-md-2 col-sm-4 col-xs-4">
<span class="text-nowrap mim-text-font">
Creation Date:
</span>
</div>
<div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
<span class="mim-text-font">
Victor A. McKusick : 4/14/2005
</span>
</div>
</div>
</div>
<div>
<a id="editHistory" class="mim-anchor"></a>
<div class="row">
<div class="col-lg-2 col-md-2 col-sm-4 col-xs-4">
<span class="text-nowrap mim-text-font">
<a href="#mimCollapseEditHistory" role="button" data-toggle="collapse"> Edit History: </a>
</span>
</div>
<div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
<span class="mim-text-font">
carol : 11/16/2022
</span>
</div>
</div>
<div class="row collapse" id="mimCollapseEditHistory">
<div class="col-lg-offset-2 col-md-offset-2 col-sm-offset-4 col-xs-offset-4 col-lg-6 col-md-6 col-sm-6 col-xs-6">
<span class="mim-text-font">
carol : 11/15/2022<br>alopez : 02/11/2021<br>carol : 04/08/2013<br>ckniffin : 4/8/2013<br>wwang : 8/11/2011<br>ckniffin : 7/28/2011<br>wwang : 1/4/2011<br>ckniffin : 12/3/2010<br>wwang : 7/2/2009<br>ckniffin : 6/17/2009<br>wwang : 5/11/2009<br>ckniffin : 4/29/2009<br>mgross : 4/15/2005
</span>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="container visible-print-block">
<div class="row">
<div class="col-md-8 col-md-offset-1">
<div>
<div>
<h3>
<span class="mim-font">
<strong>#</strong> 609310
</span>
</h3>
</div>
<div>
<h3>
<span class="mim-font">
LYNCH SYNDROME 2; LYNCH2
</span>
</h3>
</div>
<div>
<br />
</div>
<div>
<div >
<p>
<span class="mim-font">
<em>Alternative titles; symbols</em>
</span>
</p>
</div>
<div>
<h4>
<span class="mim-font">
COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2; HNPCC2<br />
COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2; FCC2<br />
COCA2
</span>
</h4>
</div>
</div>
<div>
<br />
</div>
</div>
<div>
<p>
<span class="mim-text-font">
<strong>ORPHA:</strong> 144; &nbsp;
<strong>DO:</strong> 0070274; &nbsp;
</span>
</p>
</div>
<div>
<br />
</div>
<div>
<h4>
<span class="mim-font">
<strong>Phenotype-Gene Relationships</strong>
</span>
</h4>
<div>
<table class="table table-bordered table-condensed small mim-table-padding">
<thead>
<tr class="active">
<th>
Location
</th>
<th>
Phenotype
</th>
<th>
Phenotype <br /> MIM number
</th>
<th>
Inheritance
</th>
<th>
Phenotype <br /> mapping key
</th>
<th>
Gene/Locus
</th>
<th>
Gene/Locus <br /> MIM number
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<span class="mim-font">
3p22.2
</span>
</td>
<td>
<span class="mim-font">
Lynch syndrome 2
</span>
</td>
<td>
<span class="mim-font">
609310
</span>
</td>
<td>
<span class="mim-font">
</span>
</td>
<td>
<span class="mim-font">
3
</span>
</td>
<td>
<span class="mim-font">
MLH1
</span>
</td>
<td>
<span class="mim-font">
120436
</span>
</td>
</tr>
</tbody>
</table>
</div>
</div>
<div>
<br />
</div>
<div>
<h4>
<span class="mim-font">
<strong>TEXT</strong>
</span>
</h4>
<span class="mim-text-font">
<p>A number sign (#) is used with this entry because Lynch syndrome-2 (LYNCH2), also known as hereditary nonpolyposis colorectal cancer type 2 (HNPCC2), is caused by heterozygous mutation in the MLH1 gene (120436) on chromosome 3p22.</p><p>For a general phenotypic description and a discussion of genetic heterogeneity of Lynch syndrome, see 120435.</p>
</span>
<div>
<br />
</div>
<div>
<h4>
<span class="mim-font">
<strong>Clinical Features</strong>
</span>
</h4>
</div>
<span class="mim-text-font">
<p>Barrow et al. (2008) analyzed the cumulative lifetime incidence of developing colorectal cancer by age 70 years in 121 families with genetically confirmed Lynch syndrome. Fifty-one families had MLH1 mutations, 59 had MSH2 (609309) mutations, and 11 had MSH6 (600678) mutations. The first analysis corrected for ascertainment bias by allocating mutation carrier status to a proportion of unaffected, untested family members. In this first analysis, mutation carriers had an overall 50.4% cumulative risk of developing colorectal cancer by age 70 years (54.3% in men and 46.3% in women). The risk to men with MLH1, MSH2, and MSH6 mutations was 57.9%, 53.6%, and 36.2%, respectively, whereas for women it was 50.2%, 47.7%, and 18.3%, respectively. Women mutation carriers overall had a cumulative 28.2% incidence of endometrial cancer to age 70 years. The overall risk for colorectal cancer increased to 74.5% (78.4% in men and 70.8% in women) in a second analysis that included only proven mutation carriers. In the second analysis, the cumulative risk for development of colorectal cancer by age 70 years in men was 75.4%, 83.1%, and 55.6%, for MLH1, MSH2, and MSH6 mutations, respectively. Women had a cumulative risk of 76.9%, 72.6%, and 31.4% for MLH1, MSH2, and MSH6 mutations, respectively. Cumulative 5- and 10-year survival following colorectal cancer in all mutation carriers was 56.2% and 50.0%, respectively. There were no difference in 5-year survival by mutation or gender. </p><p>Clyne et al. (2009) reported a Caucasian family with Lynch syndrome and some relatively unusual cancers associated with a heterozygous mutation in the MLH1 gene (G67E; 120436.0029). The male proband developed breast cancer and leiomyosarcoma of the thigh in his third decade, colon cancer in his fourth decade, and prostate cancer in his fifth decade. His paternal grandfather and 2 paternal uncles had colorectal cancers in the fourth decade. The proband's father had esophageal cancer at age 47 years. Other unusual tumors in carriers of the G67E mutation included cervical adenosquamous carcinoma, oligodendroglioma, and prostate cancer. </p><p>In a retrospective U.S. population-based study, Kastrinos et al. (2009) found 13 cases of pancreatic cancer among 55 families with MLH1 mutations, which corresponded to a hazard ratio of 7.5 in MLH1 mutation carriers compared to the general U.S. population. The authors concluded that pancreatic cancer is a component of HNPCC. </p>
</span>
<div>
<br />
</div>
<div>
<h4>
<span class="mim-font">
<strong>Mapping</strong>
</span>
</h4>
</div>
<span class="mim-text-font">
<p>Using RFLPs and microsatellite markers for linkage analysis in 3 HNPCC families, Lindblom et al. (1993) demonstrated linkage to 3p23-p21. Tumor DNA from 1 tumor in each family was included in the study to look for rearrangements related to tumor development. None of the colon tumors showed loss of heterozygosity (LOH) for any of the informative markers used on 20 different chromosomes. However, after they had detected linkage to 3p, Lindblom et al. (1993) observed a gain of bands for several dinucleotide markers located on 3p. A gain of bands was observed with markers on many chromosomes. </p><p>Using 19 dinucleotide markers and haplotype analysis in 2 families in which the disease was linked to 3p23-p21, Tannergard et al. (1994) localized the HNPCC2 gene specifically to 3p23-p21.3. </p><p>Between 1984 and 1994, extensive clinical and genealogic studies in Finland had identified approximately 40 hereditary nonpolyposis colorectal families that met the internationally accepted criteria for the disorder. Nystrom-Lahti et al. (1994) focused on 18 of these families. Since convincing evidence of 2p linkage had not been found in Finnish families, the role of the proposed locus on 3p was investigated. Of 18 apparently unrelated families living in different parts of Finland, 11 could be traced genealogically to a common ancestry dating at least 13 generations back in a small geographic area. Linkage studies were possible in 9 families, revealing conclusive or probable linkage to markers on 3p in 8. Of the 8, 5 were among those having shared ancestry. By analysis of recombinations in the 'linked' families, this second HNPCC locus was assigned to the 1-cM interval between marker loci D3S1561 and D3S1298. A haplotype encompassing 10 cM around the HNPCC locus was conserved in 5 of the pedigrees with shared ancestry and was present in 2 further families in which linkage analysis was not possible. The results suggested the presence of widespread single ancestral founding mutation. </p>
</span>
<div>
<br />
</div>
<div>
<h4>
<span class="mim-font">
<strong>Molecular Genetics</strong>
</span>
</h4>
</div>
<span class="mim-text-font">
<p>The mapping of MLH1 to 3p21 was of interest because markers in that area had been linked to hereditary nonpolyposis colon cancer in several families (Lindblom et al., 1993). Searching for mutations in the MLH1 gene, Papadopoulos et al. (1994) performed RT-PCR analyses of lymphoblastoid cell RNA and directly sequenced the coding region of the gene in 10 HNPCC kindreds linked to 3p markers. All affected individuals from 7 Finnish kindreds exhibited a heterozygous deletion of codons 578 to 632. The derivation of 5 of these 7 kindreds could be traced to a common ancestor, and the presence of the same presumptive defect in 2 other kindreds supported a 'founder effect' for many cases of HNPCC in the Finnish population. Codons 578 to 632 were found to constitute a single exon that was deleted from 1 allele in the 7 kindreds. This exon encodes several highly conserved amino acids found at identical positions in yeast MLH1. In another 3p-linked family, Papadopoulos et al. (1994) observed a 4-nucleotide deletion beginning at the first position of codon 727 and producing a frameshift with a new stop codon located 166 nucleotides downstream. As a result, the C-terminal 19 amino acids of MLH1 were substituted with 53 different amino acids, some encoded by nucleotides normally in the 3-prime untranslated region. Another kindred displayed a 4-nucleotide insertion between codons 755 and 756. This insertion resulted in a frameshift and extension of the open reading frame to include 99 nucleotides downstream of the normal stop codon. One cell line showed a transversion from TCA to TAA in codon 252, resulting in conversion of a serine to a stop (S152X; 120436.0001). </p><p>Simultaneously and independently, Bronner et al. (1994) likewise implicated the human MutL homolog, MLH1, in the form of HNPCC that maps to 3p. In 1 chromosome 3-linked HNPCC family, they demonstrated a heterozygous missense mutation in affected individuals (S44F; 120436.0002). </p><p>Hemminki et al. (1994) noted that studies in vitro indicate that heterozygosity of mutations in DNA MMR genes, unlike homozygosity, does not affect mismatch repair. Hemminki et al. (1994) demonstrated that loss of heterozygosity of markers within or adjacent to the MLH1 gene on 3p occurs nonrandomly in tumors from members of families in which the HNPCC phenotype cosegregates with MLH1. In every informative case, the loss affected the wildtype allele. These results suggested that DNA MMR genes resemble tumor suppressor genes in that 2 hits are required to cause a phenotypic effect. </p><p>Hamilton et al. (1995) identified a patient (family 14) with hereditary colon cancer who carried a heterozygous mutation in the MLH1 gene (120436.0003). The patient was a 39-year-old male who had adenocarcinoma of the ascending and transverse colon at age 30 years, adenomas of the descending and sigmoid colon at age 32 and 33 years, respectively, and an ileal adenocarcinoma at age 33, as well as transitional cell carcinoma of the ureter. He was found to have glioblastoma at age 33 years. </p><p>Bapat et al. (1999) screened the MSH2 and MLH1 genes for germline mutations in 33 cases/families who met Mount Sinai criteria for familial colorectal cancer, only 14 of whom met the more stringent Amsterdam criteria. Mutations were identified in 8 of 14 Amsterdam criteria families and 5 of 19 remaining, 3 of whom had features of the Muir-Torre syndrome (158320). A high level of microsatellite instability (MSI) was detected in 16 of 18 colorectal cancers from individuals with MSH2 and MLH1 mutations and infrequently (1 of 21) in colorectal cancers from individuals without detectable mutations. Families with germline mutations had individuals affected at younger ages and with multiple tumors. The authors suggested that colorectal cancer family criteria need revision to more accurately identify those who would benefit from MSH2 and MLH1 mutation analysis. </p><p>Jager et al. (1997) reported studies based on the Danish HNPCC register comprising 28 families that fulfilled the Amsterdam criteria (Vasen et al., 1991): i.e., (1) families should exhibit 3 histologically verified cases of colorectal cancer, of which at least 1 should be diagnosed before the age of 50 years; (2) there should be affected individuals in 2 generations, and 1 of these individuals should be a first-degree relative to the other 2; and (3) familial adenomatous polyposis should be excluded. In this study, Jager et al. (1997) found an intron 14 founder mutation in the MLH1 gene (120436.0007) in approximately 25% of the kindreds and showed that it was associated with an attenuated HNPCC phenotype characterized by a highly reduced frequency of extracolonic tumors. The mutation was a combined 7-bp deletion and 4-bp insertion that 'silenced the mutated allele,' i.e., it was not expressed. Tumors exhibited microsatellite instability, and loss of the wildtype MLH1 allele was prevalent. Jager et al. (1997) proposed that the mutation resulted in a milder phenotype because the mutated MLH1 protein was prevented from exerting a dominant-negative effect on the concerted action of the mismatch repair system. </p><p>Cunningham et al. (2001) analyzed somatic and germline mutations in the DNA mismatch repair genes to clarify the prevalence and mechanism of inactivation in colorectal cancer. They examined 257 unselected patients referred for colorectal cancer resection for evidence of defective DNA MMR. MMR status was assessed by the testing of tumors for the presence or absence of MLH1, MSH2, and MSH6 protein expression and for microsatellite instability. Of the 257 patients, 51 (20%) had evidence of defective MMR, demonstrating high levels of MSI and an absence of either MLH1 (48 patients) or MSH2 (3 patients). All 3 patients lacking MSH2, as well as 1 patient lacking MLH1, also demonstrated an absence of MSH6. DNA sequence analysis of the 51 patients with defective MMR revealed 7 germline mutations: 4 in MLH1 (2 truncating, 2 missense) and 3 in MSH2 (all truncating). A detailed family history was available for 225 of the 257 patients. Of the 7 patients with germline mutations, only 3 had family histories consistent with HNPCC. Of the remaining patients who had tumors with defective MMR, 8 had somatic mutations in MLH1. In addition, hypermethylation of the MLH1 gene promoter was present in 37 (88%) of the 42 MLH1-negative cases available for study and in all tumors demonstrating a high level of MSI that showed loss of MLH1 expression but no detectable MLH1 mutations. The results suggested that, although defective DNA MMR occurs in approximately 20% of unselected patients presenting for colorectal cancer resection, hereditary colorectal cancer due to mutations in the MMR pathway account for only a small proportion of patients. Of the 257 patients, only 5 (1.9%) appeared to have unequivocal evidence of hereditary defects in MMR. The epigenetic (nonhereditary) mechanism of MLH1 promoter hypermethylation appears to be responsible for most of the remaining patients whose tumors are characterized by defective DNA MMR. </p><p>In hereditary nonpolyposis colorectal cancer, a large proportion of mutations detected in MSH2 (609309) are of the missense type; these may represent deleterious sequence changes or harmless polymorphisms. In order to determine whether such sequence changes could be interpreted as pathogenic, Cravo et al. (2002) investigated 10 Portuguese families with a history of colorectal cancer in whom a missense or splice site mutation in either MSH2 or MLH1 had been detected in the proband. In most families there was no definite evidence that the missense mutations or splice site mutations were causally associated with an increased risk of developing colorectal carcinoma. The authors suggested that such mutational events should be interpreted with great caution. </p>
</span>
<div>
<br />
</div>
<div>
<h4>
<span class="mim-font">
<strong>Genotype/Phenotype Correlations</strong>
</span>
</h4>
</div>
<span class="mim-text-font">
<p><strong><em>MSH2 Versus MLH1 Mutations in Lynch Syndrome</em></strong></p><p>
Approximately 35% of families in which the diagnosis of HNPCC is based on the Amsterdam criteria do not appear to harbor mutations in the DNA-mismatch repair genes. Scott et al. (2001) presented data from a large series of families with HNPCC. They found subtle differences between families that harbor germline changes in MSH2 and families that harbor MLH1 mutations. Furthermore, there were differences between the mutation-positive group (MSH2 and MLH1 combined) of families and the mutation-negative group of families. The major findings identified in this study focused primarily on the extracolonic disease profile observed between the mutation-positive families and the mutation-negative families. Breast cancer was not significantly overrepresented in the MSH2 mutation-positive group but was overrepresented in the MLH1 mutation-positive group and in the mutation-negative group. Prostate cancer was not overrepresented in the mutation-positive group but was overrepresented in the mutation-negative group. In age at diagnosis of colorectal cancer, there was no difference between the MSH2 mutation-positive group and the MLH1 mutation-positive group, but there was a significant difference between these 2 groups and the mutation-negative group. </p><p>Van der Post et al. (2010) used a questionnaire-based survey to ascertain the risk of urogenital cancer in 95 HNPCC families, including 26 with MLH1 mutations, 43 with MSH2 mutations, and 26 with MSH6 (600678) mutations. Bladder cancer was diagnosed in 21 patients (90% men) from 19 families: 15 with MSH2 mutations, 4 with MSH6 mutations, and 2 with MLH1 mutations. The relative risks for all mutation carriers and first degree relatives was 4.2 for men and 2.2 for women compared to the general Dutch population. Male MSH2 mutation carriers and their male first degree relatives were at highest risks, with a cumulative risk by age 70 being 12.3% for bladder cancer and 5.9% for upper urinary tract cancer. Male MLH1 mutation carriers and their male first degree relatives had a cumulative risk of 10.8% and 4.8% for bladder and upper urinary tract cancer, respectively, by age 70. Van der Post et al. (2010) concluded that patients with Lynch syndrome, particularly those carrying MSH2 mutations, have an increased risk of urinary tract cancer, which may warrant surveillance. </p>
</span>
<div>
<br />
</div>
<div>
<h4>
<span class="mim-font">
<strong>Population Genetics</strong>
</span>
</h4>
</div>
<span class="mim-text-font">
<p>In a population-based survey, Tang et al. (2009) identified pathogenic mutations or deletions in the MLH1 or MSH2 gene in 61 (66%) of 93 Taiwanese families with HNPCC. Forty-two families had MLH1 mutations, including 13 with the R265C mutation (120436.0030) and 5 with a 3-bp deletion (1846delAAG; 120436.0018). Thirteen of the MLH1 mutations were novel, and 6 large MLH1 deletions were also found. One family harbored MSH2 and MLH1 mutations. </p><p>In a registry-based and population-based survey of 166 MLH1 mutation-carrying families, Dowty et al. (2013) estimated that the cumulative risk of colorectal cancer was 34% (25-50%) for male carriers and 36% (25-51%) for female carriers by age 70 years. The risk for endometrial cancer was 18% (9.1-34%). There was great individual risk heterogeneity, perhaps due to other genetic alterations or environmental factors. Compared to MLH1 mutation families, families with MSH2 mutations had almost twice as many extraintestinal cancers. </p>
</span>
<div>
<br />
</div>
</div>
<div>
<h4>
<span class="mim-font">
<strong>REFERENCES</strong>
</span>
</h4>
<div>
<p />
</div>
<div>
<ol>
<li>
<p class="mim-text-font">
Bapat, B. V., Madlensky, L., Temple, L. K. F., Hiruki, T., Redston, M., Baron, D. L., Xia, L., Marcus, V. A., Soravia, C., Mitri, A., Shen, W., Gryfe, R., Berk, T., Chodirker, B. N., Cohen, Z., Gallinger, S.
<strong>Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.</strong>
Hum.Genet . 104: 167-176, 1999.
[PubMed: 10190329]
[Full Text: https://doi.org/10.1007/s004390050931]
</p>
</li>
<li>
<p class="mim-text-font">
Barrow, E., Alduaij, W., Robinson, L., Shenton, A., Clancy, T., Lalloo, F., Hill, J., Evans, D. G.
<strong>Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.</strong>
Clin. Genet. 74: 233-242, 2008.
[PubMed: 18554281]
[Full Text: https://doi.org/10.1111/j.1399-0004.2008.01035.x]
</p>
</li>
<li>
<p class="mim-text-font">
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., Tannergard, P., Bollag, R. J., Godwin, A. R., Ward, D. C., Nordenskjold, M., Fishel, R., Kolodner, R., Liskay, R. M.
<strong>Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer.</strong>
Nature 368: 258-261, 1994.
[PubMed: 8145827]
[Full Text: https://doi.org/10.1038/368258a0]
</p>
</li>
<li>
<p class="mim-text-font">
Clyne, M., Offman, J., Shanley, S., Virgo, J. D., Radulovic, M., Wang, Y., Ardern-Jones, A., Eeles, R., Hoffmann, E., Yu, V. P. C. C.
<strong>The G67E mutation in hMLH1 is associated with an unusual presentation of Lynch syndrome.</strong>
Brit. J. Cancer 100: 376-380, 2009.
[PubMed: 19142183]
[Full Text: https://doi.org/10.1038/sj.bjc.6604860]
</p>
</li>
<li>
<p class="mim-text-font">
Cravo, M., Afonso, A. J.., Lage, P., Albuquerque, C., Maia, L., Lacerda, C., Fidalgo, P., Chaves, P., Cruz, C., Nobre-Leitao, C.
<strong>Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing.</strong>
Gut 50: 405-412, 2002.
[PubMed: 11839723]
[Full Text: https://doi.org/10.1136/gut.50.3.405]
</p>
</li>
<li>
<p class="mim-text-font">
Cunningham, J. M., Kim, C.-Y., Christensen, E. R., Tester, D. J., Parc, Y., Burgart, L. J., Halling, K. C., McDonnell, S. K., Schaid, D. J., Vockley, C. W., Kubly, V., Nelson, H., Michels, V. V., Thibodeau, S. N.
<strong>The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.</strong>
Am. J. Hum. Genet. 69: 780-790, 2001. Note: Erratum: Am. J. Hum. Genet. 69: 1160 only, 2001.
[PubMed: 11524701]
[Full Text: https://doi.org/10.1086/323658]
</p>
</li>
<li>
<p class="mim-text-font">
Dowty, J. G., Win, A. K., Buchanan, D. D., Lindor, N. M., Macrae, F. A., Clendenning, M., Antill, Y. C., Thibodeau, S. N., Casey, G., Gallinger, S., Le Marchand, L., Newcomb, P. A., and 15 others.
<strong>Cancer risks for MLH1 and MSH2 mutation carriers.</strong>
Hum. Mutat. 34: 490-497, 2013.
[PubMed: 23255516]
[Full Text: https://doi.org/10.1002/humu.22262]
</p>
</li>
<li>
<p class="mim-text-font">
Hamilton, S. R., Liu, B., Parsons, R. E., Papadopoulos, N., Jen, J., Powell, S. M., Krush, A. J., Berk, T., Cohen, Z., Tetu, B., Burger, P. C., Wood, P. A., Taqi, F., Booker, S. V., Petersen, G. M., Offerhaus, G. J. A., Tersmette, A. C., Giardiello, F. M., Vogelstein, B., Kinzler, K. W.
<strong>The molecular basis of Turcot&#x27;s syndrome.</strong>
New Eng. J. Med. 332: 839-847, 1995.
[PubMed: 7661930]
[Full Text: https://doi.org/10.1056/NEJM199503303321302]
</p>
</li>
<li>
<p class="mim-text-font">
Hemminki, A., Peltomaki, P., Mecklin, J.-P., Jarvinen, H., Salovaara, R., Nystrom-Lahti, M., de la Chapelle, A., Aaltonen, L. A.
<strong>Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer.</strong>
Nature Genet. 8: 405-410, 1994.
[PubMed: 7894494]
[Full Text: https://doi.org/10.1038/ng1294-405]
</p>
</li>
<li>
<p class="mim-text-font">
Jager, A. C., Bisgaard, M. L., Myrhoj, T., Bernstein, I., Rehfeld, J. F., Nielsen, F. C.
<strong>Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression.</strong>
Am. J. Hum. Genet. 61: 129-138, 1997.
[PubMed: 9245993]
[Full Text: https://doi.org/10.1086/513896]
</p>
</li>
<li>
<p class="mim-text-font">
Kastrinos, F., Mukherjee, B., Tayob, N., Wang, F., Sparr, J., Raymond, V. M., Bandipalliam, P., Stoffel, E. M., Gruber, S. B., Syngal, S.
<strong>Risk of pancreatic cancer in families with Lynch syndrome.</strong>
JAMA 302: 1790-1795, 2009.
[PubMed: 19861671]
[Full Text: https://doi.org/10.1001/jama.2009.1529]
</p>
</li>
<li>
<p class="mim-text-font">
Lindblom, A., Tannergard, P., Werelius, B., Nordenskjold, M.
<strong>Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer.</strong>
Nature Genet. 5: 279-282, 1993.
[PubMed: 7903889]
[Full Text: https://doi.org/10.1038/ng1193-279]
</p>
</li>
<li>
<p class="mim-text-font">
Nystrom-Lahti, M., Sistonen, P., Mecklin, J.-P., Pylkkanen, L., Aaltonen, L. A., Jarvinen, H., Weissenbach, J., de la Chapelle, A., Peltomaki, P.
<strong>Close linkage to chromosome 3p and conservation of ancestral founding haplotype in hereditary nonpolyposis colorectal cancer families.</strong>
Proc. Nat. Acad. Sci. 91: 6054-6058, 1994.
[PubMed: 8016114]
[Full Text: https://doi.org/10.1073/pnas.91.13.6054]
</p>
</li>
<li>
<p class="mim-text-font">
Papadopoulos, N., Nicolaides, N. C., Wei, Y.-F., Ruben, S. M., Carter, K. C., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., Adams, M. D., Venter, J. C., Hamilton, S. R., Petersen, G. M., Watson, P., Lynch, H. T., Peltomaki, P., Mecklin, J.-P., de la Chapelle, A., Kinzler, K. W., Vogelstein, B.
<strong>Mutation of a mutL homolog in hereditary colon cancer.</strong>
Science 263: 1625-1629, 1994.
[PubMed: 8128251]
[Full Text: https://doi.org/10.1126/science.8128251]
</p>
</li>
<li>
<p class="mim-text-font">
Scott, R. J., McPhillips, M., Meldrum, C. J., Fitzgerald, P. E., Adams, K., Spigelman, A. D., du Sart, D., Tucker, K., Kirk, J., Hunter Family Cancer Service.
<strong>Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds.</strong>
Am. J. Hum. Genet. 68: 118-127, 2001. Note: Erratum: Am. J. Hum. Genet. 68: 557 only, 2001.
[PubMed: 11112663]
[Full Text: https://doi.org/10.1086/316942]
</p>
</li>
<li>
<p class="mim-text-font">
Tang, R., Hsiung, C., Wang, J.-Y., Lai, C.-H., Chien, H.-T., Chiu, L.-L., Liu, C.-T., Chen, H.-H., Wang, H.-M., Chen, S.-X., Hsieh, L.-L., the TCOG HNPCC Consortium.
<strong>Germ line MLH1 and MSH2 mutations in Taiwanese Lynch syndrome families: characterization of a founder genomic mutation in the MLH1 gene.</strong>
Clin. Genet. 75: 334-345, 2009.
[PubMed: 19419416]
[Full Text: https://doi.org/10.1111/j.1399-0004.2009.01162.x]
</p>
</li>
<li>
<p class="mim-text-font">
Tannergard, P., Zabarovsky, E., Stanbridge, E., Nordenskjold, M., Lindblom, A.
<strong>Sublocalization of a locus at 3p21.3-23 predisposing to hereditary nonpolyposis colon cancer.</strong>
Hum. Genet. 94: 210-214, 1994.
[PubMed: 8045572]
[Full Text: https://doi.org/10.1007/BF00202874]
</p>
</li>
<li>
<p class="mim-text-font">
van der Post, R. S., Kiemeney, L. A., Ligtenberg, M. J. L., Witjes, J. A., Hulsbergen-van de Kaa, C. A., Bodmer, D., Schaap, L., Kets, C. M., van Krieken, J. H. J. M., Hoogerbrugge, N.
<strong>Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.</strong>
J. Med. Genet. 47: 464-470, 2010.
[PubMed: 20591884]
[Full Text: https://doi.org/10.1136/jmg.2010.076992]
</p>
</li>
<li>
<p class="mim-text-font">
Vasen, H. F., Mecklin, J. P., Khan, P. M., Lynch, H. T.
<strong>The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).</strong>
Dis. Colon Rectum 34: 424-425, 1991.
[PubMed: 2022152]
[Full Text: https://doi.org/10.1007/BF02053699]
</p>
</li>
</ol>
<div>
<br />
</div>
</div>
</div>
<div>
<div class="row">
<div class="col-lg-1 col-md-1 col-sm-2 col-xs-2">
<span class="text-nowrap mim-text-font">
Contributors:
</span>
</div>
<div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
<span class="mim-text-font">
Cassandra L. Kniffin - updated : 4/8/2013<br>Cassandra L. Kniffin - updated : 7/28/2011<br>Cassandra L. Kniffin - updated : 6/17/2009<br>Cassandra L. Kniffin - updated : 4/29/2009
</span>
</div>
</div>
</div>
<div>
<br />
</div>
<div>
<div class="row">
<div class="col-lg-1 col-md-1 col-sm-2 col-xs-2">
<span class="text-nowrap mim-text-font">
Creation Date:
</span>
</div>
<div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
<span class="mim-text-font">
Victor A. McKusick : 4/14/2005
</span>
</div>
</div>
</div>
<div>
<br />
</div>
<div>
<div class="row">
<div class="col-lg-1 col-md-1 col-sm-2 col-xs-2">
<span class="text-nowrap mim-text-font">
Edit History:
</span>
</div>
<div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
<span class="mim-text-font">
carol : 11/16/2022<br>carol : 11/15/2022<br>alopez : 02/11/2021<br>carol : 04/08/2013<br>ckniffin : 4/8/2013<br>wwang : 8/11/2011<br>ckniffin : 7/28/2011<br>wwang : 1/4/2011<br>ckniffin : 12/3/2010<br>wwang : 7/2/2009<br>ckniffin : 6/17/2009<br>wwang : 5/11/2009<br>ckniffin : 4/29/2009<br>mgross : 4/15/2005
</span>
</div>
</div>
</div>
<div>
<br />
</div>
</div>
</div>
</div>
</div>
<div id="mimFooter">
<div class="container ">
<div class="row">
<br />
<br />
</div>
</div>
<div class="hidden-print mim-footer">
<div class="container">
<div class="row">
<p />
</div>
<div class="row text-center small">
NOTE: OMIM is intended for use primarily by physicians and other professionals concerned with genetic disorders, by genetics researchers,
and by advanced students in science and medicine. While the OMIM database is open to the public, users seeking information about a personal
medical or genetic condition are urged to consult with a qualified physician for diagnosis and for answers to personal questions.
<br />
OMIM<sup>&reg;</sup> and Online Mendelian Inheritance in Man<sup>&reg;</sup> are registered trademarks of the Johns Hopkins University.
<br />
Copyright<sup>&reg;</sup> 1966-2025 Johns Hopkins University.
</div>
</div>
</div>
<div class="visible-print-block mim-footer" style="position: relative;">
<div class="container">
<div class="row">
<p />
</div>
<div class="row text-center small">
NOTE: OMIM is intended for use primarily by physicians and other professionals concerned with genetic disorders, by genetics researchers,
and by advanced students in science and medicine. While the OMIM database is open to the public, users seeking information about a personal
medical or genetic condition are urged to consult with a qualified physician for diagnosis and for answers to personal questions.
<br />
OMIM<sup>&reg;</sup> and Online Mendelian Inheritance in Man<sup>&reg;</sup> are registered trademarks of the Johns Hopkins University.
<br />
Copyright<sup>&reg;</sup> 1966-2025 Johns Hopkins University.
<br />
Printed: March 5, 2025
</div>
</div>
</div>
</div>
<div class="modal fade" id="mimDonationPopupModal" tabindex="-1" role="dialog" aria-labelledby="mimDonationPopupModalTitle">
<div class="modal-dialog" role="document">
<div class="modal-content">
<div class="modal-header">
<button type="button" id="mimDonationPopupCancel" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">&times;</span></button>
<h4 class="modal-title" id="mimDonationPopupModalTitle">
OMIM Donation:
</h4>
</div>
<div class="modal-body">
<div class="row">
<div class="col-lg-offset-1 col-md-offset-1 col-sm-offset-1 col-xs-offset-1 col-lg-10 col-md-10 col-sm-10 col-xs-10">
<p>
Dear OMIM User,
</p>
</div>
</div>
<div class="row">
<div class="col-lg-offset-1 col-md-offset-1 col-sm-offset-1 col-xs-offset-1 col-lg-10 col-md-10 col-sm-10 col-xs-10">
<p>
To ensure long-term funding for the OMIM project, we have diversified
our revenue stream. We are determined to keep this website freely
accessible. Unfortunately, it is not free to produce. Expert curators
review the literature and organize it to facilitate your work. Over 90%
of the OMIM's operating expenses go to salary support for MD and PhD
science writers and biocurators. Please join your colleagues by making a
donation now and again in the future. Donations are an important
component of our efforts to ensure long-term funding to provide you the
information that you need at your fingertips.
</p>
</div>
</div>
<div class="row">
<div class="col-lg-offset-1 col-md-offset-1 col-sm-offset-1 col-xs-offset-1 col-lg-10 col-md-10 col-sm-10 col-xs-10">
<p>
Thank you in advance for your generous support, <br />
Ada Hamosh, MD, MPH <br />
Scientific Director, OMIM <br />
</p>
</div>
</div>
</div>
<div class="modal-footer">
<button type="button" id="mimDonationPopupDonate" class="btn btn-success btn-block" data-dismiss="modal"> Donate To OMIM! </button>
</div>
</div>
</div>
</div>
</div>
</body>
</html>